data_2bgp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bgp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CE3' ' N ' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.522 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' CB ' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.477 HD13 HD21 ' A' ' 24' ' ' LEU . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 28' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 8.5 p30 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.513 ' O ' HG11 ' A' ' 25' ' ' VAL . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.455 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' CG1' ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.448 ' CG1' ' HG ' ' A' ' 119' ' ' LEU . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.475 ' CD2' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.498 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.479 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.526 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 101' ' ' GLY . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.405 ' HE3' ' HG ' ' A' ' 54' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.412 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 70' ' ' ASP . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' CG2' HG23 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.426 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 3.0 m120 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' CG2' ' A' ' 102' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.494 HD11 ' HA3' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.448 ' HG ' ' CG1' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.437 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 11.2 m-90 -104.46 104.75 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -98.63 98.59 9.72 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 178.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.525 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -80.67 94.95 6.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.958 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 155.43 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.806 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -72.09 -19.49 61.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.91 -13.5 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.82 -24.13 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.976 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . . . -79.92 -176.38 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.5 p -107.79 114.36 28.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -85.54 114.13 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -96.46 116.21 28.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.33 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.54 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -46.96 151.45 1.13 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.028 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 36' ' ' SER . 55.5 Cg_endo -67.02 3.33 2.38 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.044 -1.232 . . . . 0.0 113.409 0.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.54 ' N ' ' HA ' ' A' ' 20' ' ' ALA . . . -59.59 139.79 56.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.019 0.437 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.1 147.1 45.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -91.27 101.05 13.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.773 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 24.7 m -100.54 98.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.857 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.55 60.48 8.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.262 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 1.0 OUTLIER 58.01 21.65 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.831 0.348 . . . . 0.0 110.903 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 t -127.91 118.64 49.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -67.15 149.89 51.45 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.172 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.7 mm-40 -140.06 158.67 43.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 112' ' ' MET . 0.0 OUTLIER -145.17 153.21 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.309 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 11.1 mt-30 -151.32 92.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 111.094 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.05 -173.52 34.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.388 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.36 146.9 34.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.16 -24.74 25.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.003 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -82.06 151.24 27.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.861 0.33 . . . . 0.0 110.433 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.04 133.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -108.67 89.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.984 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.89 153.36 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.209 0.528 . . . . 0.0 112.146 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 1.4 m-90 -125.47 148.65 48.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.752 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -119.5 111.71 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.613 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.1 m -157.66 -179.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.194 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -124.99 137.74 54.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 98' ' ' HIS . 87.4 t -59.96 138.63 90.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.437 ' HG3' ' CH2' ' A' ' 9' ' ' TRP . 33.7 Cg_endo -65.32 -56.12 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.525 2.15 . . . . 0.0 112.583 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.45 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 0.0 111.802 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.6 p -107.85 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.9 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.23 -157.49 9.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 35.1 tt0 -110.33 123.2 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.489 ' CD2' ' CD1' ' A' ' 93' ' ' LEU . 3.7 m-85 -123.45 146.88 47.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -88.71 119.04 28.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.427 HD12 ' HD3' ' A' ' 91' ' ' LYS . 5.3 mt -78.95 146.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 2.2 m-20 -138.77 112.8 8.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.406 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.562 ' HG ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.41 118.72 36.65 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.134 0.492 . . . . 0.0 110.328 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.5 m -105.13 129.23 53.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.145 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.551 ' HZ3' ' O ' ' A' ' 79' ' ' ALA . 1.6 p-90 -160.03 148.72 17.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 81' ' ' ALA . 0.9 OUTLIER -161.24 109.32 1.52 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 10.0 m -154.0 84.68 4.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 52.6 Cg_exo -56.13 85.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.574 2.182 . . . . 0.0 112.078 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -117.38 -92.89 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.665 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -139.41 -106.52 0.17 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 12.8 t -175.8 144.23 0.62 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.898 0.38 . . . . 0.0 111.582 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 169.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.855 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.76 160.33 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.845 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -159.56 166.46 30.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.31 136.96 47.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.764 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 102' ' ' VAL . 12.5 tp -118.12 103.87 10.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 11.1 t -85.95 110.04 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.562 ' HE3' ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -126.3 101.21 6.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.489 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' HB2' ' CE ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER 78.58 32.81 0.3 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.869 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.0 16.89 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.937 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 128.42 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . . . -98.0 99.03 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.22 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -80.34 131.32 35.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.74 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.5 t -79.81 105.97 11.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.012 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 3.5 t80 -127.34 120.04 27.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.472 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.52 141.99 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.545 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -169.94 -93.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.149 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.551 ' O ' ' HZ3' ' A' ' 56' ' ' TRP . . . -169.15 -153.92 0.12 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.417 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.486 ' HG2' ' CB ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -104.96 32.39 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.253 0.549 . . . . 0.0 109.711 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.532 ' CB ' ' CE3' ' A' ' 56' ' ' TRP . . . 47.46 -168.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.949 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 59' ' ' PRO . 2.4 t -160.4 -41.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.028 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -118.36 -175.85 0.35 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.857 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' N ' HG21 ' A' ' 83' ' ' VAL . 14.5 Cg_exo -67.22 63.0 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.523 1.482 . . . . 0.0 109.813 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 83' ' ' VAL . 26.0 t -79.34 113.51 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.064 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 60.4 p -97.69 156.14 16.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.507 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.47 ' CG ' ' OE1' ' A' ' 89' ' ' GLN . 5.7 t80 -129.18 129.07 44.6 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.51 134.69 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 112.123 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.47 ' OE1' ' CG ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -144.25 112.29 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.747 178.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p -80.27 117.51 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD3' HD12 ' A' ' 52' ' ' ILE . 3.1 ttpt -155.58 145.51 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 3.9 p -94.95 146.06 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.474 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.489 ' CD1' ' CD2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -124.87 143.96 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.45 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -95.44 163.14 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.612 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.78 122.03 24.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.169 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.76 -148.05 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.07 144.54 26.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.42 ' CE1' HG22 ' A' ' 44' ' ' VAL . 73.4 m80 -154.53 147.03 24.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 p -96.74 144.72 26.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.689 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -142.24 170.16 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.255 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' HA3' HD12 ' A' ' 117' ' ' LEU . . . 137.09 170.49 11.92 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.62 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -119.19 112.77 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 -179.43 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.375 0.607 . . . . 0.0 112.425 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.9 t -146.36 122.78 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.1 -170.32 12.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -32.34 69.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.935 0.398 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -65.64 -28.15 68.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.735 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -153.82 67.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -68.51 154.16 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.34 -170.62 25.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.46 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -123.36 150.86 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.056 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.475 ' HG2' ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -163.86 145.42 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.659 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 8.8 t-20 -80.93 170.47 16.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.603 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 29' ' ' GLY . 57.1 t -154.4 106.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.083 0.468 . . . . 0.0 110.773 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 116' ' ' SER . 37.7 t-80 -87.44 -55.45 3.79 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.565 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 3.4 t -177.0 137.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.52 ' CD1' ' CZ3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -87.06 111.56 21.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.808 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' TRP . 0.4 OUTLIER -120.16 130.3 54.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.501 . . . . 0.0 112.291 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.69 107.78 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.301 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -99.53 151.58 20.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.019 0.437 . . . . 0.0 111.877 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.3 138.87 58.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.736 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 7.3 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.743 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.516 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -123.59 135.88 54.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.442 . . . . 0.0 111.673 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 160.27 15.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.252 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -137.78 94.72 2.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.962 0.411 . . . . 0.0 110.746 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 p -70.45 142.59 51.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.387 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.77 -19.77 64.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.597 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -30.82 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -104.86 29.92 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . . . -123.68 -165.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.7 m -114.02 104.09 11.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.41 HD11 HG11 ' A' ' 38' ' ' VAL . 1.5 mm -85.43 95.24 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.4 m -79.95 120.59 24.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.566 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -52.04 155.29 3.32 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.856 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 36' ' ' SER . 56.0 Cg_endo -67.99 4.86 2.49 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.985 -1.256 . . . . 0.0 113.316 0.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.566 ' N ' ' HA ' ' A' ' 20' ' ' ALA . . . -59.57 142.01 53.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 110.52 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -137.64 145.05 42.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -91.68 95.5 9.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 11.5 m -94.61 98.76 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.053 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.49 59.96 9.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.577 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 0.6 OUTLIER 59.72 20.72 9.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.717 0.294 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 114' ' ' VAL . 1.6 t -131.91 122.96 50.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD1' ' A' ' 113' ' ' ASN . . . -67.22 147.83 49.49 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.203 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 5.2 mt-10 -144.48 105.0 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 111.259 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 0.3 OUTLIER -88.65 159.67 17.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.125 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -154.81 87.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.821 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.2 175.1 45.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.364 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.01 151.05 43.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.08 -27.99 15.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.813 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.551 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.57 151.59 37.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.508 0.194 . . . . 0.0 110.483 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.15 107.13 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -89.25 89.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.6 mm -95.39 157.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 112.523 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.502 ' CZ3' HD11 ' A' ' 117' ' ' LEU . 4.6 m-90 -130.86 146.5 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.365 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.18 111.9 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.82 -176.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.88 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.65 135.7 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.399 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.3 t -69.24 130.1 91.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.569 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.516 ' HG3' ' CH2' ' A' ' 9' ' ' TRP . 71.9 Cg_endo -76.92 -45.01 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.343 2.029 . . . . 0.0 113.033 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.28 163.67 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 111.881 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.1 p -94.79 72.28 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.26 -132.62 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.802 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 37.0 tt0 -132.16 149.42 52.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.954 0.407 . . . . 0.0 111.227 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.477 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 20.5 m-85 -137.57 160.83 38.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.232 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.548 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.25 128.27 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.746 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -99.13 149.05 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.42 119.44 7.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -99.58 123.86 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 133.78 51.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.266 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.547 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -157.9 154.54 28.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.342 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.82 81.19 0.57 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -116.44 90.68 31.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.488 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 31.3 Cg_exo -61.59 61.58 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.215 1.944 . . . . 0.0 113.504 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -166.81 -88.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.481 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -45.19 174.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 45.5 m -173.94 105.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.778 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -171.16 161.45 6.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.871 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 12.0 t -56.53 163.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' MET . 24.3 t-20 -160.86 161.5 31.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.039 0.447 . . . . 0.0 111.433 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.12 137.19 41.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.467 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -108.49 107.61 18.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -91.06 96.85 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.953 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.45 ' HB3' ' CD1' ' A' ' 52' ' ' ILE . 4.4 mmt -132.95 114.4 13.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.432 ' N ' ' CE1' ' A' ' 100' ' ' PHE . 20.4 t0 65.55 41.69 4.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.1 26.07 71.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -128.64 122.88 31.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.43 93.89 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 1.4 pp -83.21 127.45 33.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.045 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.1 t -79.91 122.14 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -155.71 151.27 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.44 125.86 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.139 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' CD2' ' CZ2' ' A' ' 56' ' ' TRP . 8.3 m-85 -133.88 94.99 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.831 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 62' ' ' SER . . . -86.79 132.14 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.607 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.5 OUTLIER -51.45 88.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.68 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.64 161.47 29.66 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.262 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.488 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -103.21 -33.96 9.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.947 0.403 . . . . 0.0 110.995 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' VAL . 49.5 t -79.89 136.09 54.91 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.328 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.27 82.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.347 2.031 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 83' ' ' VAL . 23.1 t -84.05 139.5 17.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.32 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -122.54 114.3 20.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.973 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -93.73 105.66 17.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 38.3 t -79.93 129.52 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 4.7 mt-30 -144.22 127.76 17.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.2 p -104.8 137.28 42.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.933 0.397 . . . . 0.0 111.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HD2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.83 156.53 25.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.312 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -92.34 134.58 34.78 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.898 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.477 ' CD2' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.48 144.36 51.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.902 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 p -102.58 143.69 31.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.83 122.05 6.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.371 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.08 -155.86 26.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.8 129.29 41.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -144.2 135.92 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -88.12 128.79 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CE1' ' N ' ' A' ' 70' ' ' ASP . 27.2 m-85 -128.42 147.39 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.33 -155.4 26.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.194 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -144.07 122.89 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.713 -0.244 . . . . 0.0 110.447 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.6 173.22 10.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.154 0.502 . . . . 0.0 111.894 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.421 ' CG1' ' HA ' ' A' ' 109' ' ' TRP . 47.0 t -126.89 128.28 70.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.659 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.43 -170.96 14.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.792 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -59.51 -37.43 78.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -62.06 -28.99 69.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.8 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -158.1 88.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.421 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -90.05 145.65 24.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.895 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.25 170.52 18.25 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.814 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.79 149.24 22.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.441 ' CE ' ' O ' ' A' ' 113' ' ' ASN . 3.9 tpt -164.41 130.04 2.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.662 0.268 . . . . 0.0 111.174 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.564 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 26.8 t30 -80.78 172.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 38' ' ' VAL . 11.0 t -153.85 119.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.1 OUTLIER -96.82 -58.94 1.91 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.99 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -179.41 144.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.502 HD11 ' CZ3' ' A' ' 40' ' ' TRP . 8.1 mp -88.31 159.84 17.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 9.6 tppt? -136.29 140.57 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -150.0 107.94 3.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.15 178.29 5.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.193 0.52 . . . . 0.0 111.752 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.435 HD23 ' CE1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -77.95 59.48 2.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.091 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 6.0 mp . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.519 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.446 ' CZ3' ' HG3' ' A' ' 45' ' ' PRO . 20.0 m-90 -158.46 106.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.476 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.31 148.71 23.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.276 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CB ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -124.83 100.75 6.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.653 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -66.85 148.9 51.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.52 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 24' ' ' LEU . . . -63.15 -24.08 67.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.498 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.82 -24.71 63.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 94.1 p -107.31 29.53 7.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.765 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . . . -124.6 -165.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.75 104.21 12.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.516 HD12 HD22 ' A' ' 24' ' ' LEU . 15.6 mm -79.79 98.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.3 m -83.8 115.96 22.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.194 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -51.65 154.0 3.69 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 36' ' ' SER . 53.0 Cg_endo -66.82 1.94 2.58 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.11 -1.204 . . . . 0.0 113.472 0.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.534 ' N ' ' HA ' ' A' ' 20' ' ' ALA . . . -59.4 141.66 54.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -141.65 144.61 34.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.539 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD22 HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.93 91.04 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.782 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 28' ' ' VAL . 5.2 m -90.38 109.34 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.742 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.63 55.51 28.31 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.684 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 3.7 m120 58.49 20.88 7.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.195 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' VAL . 3.6 t -134.61 144.55 34.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.232 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' VAL . . . -78.5 143.17 26.7 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.762 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.8 OUTLIER -144.15 110.76 5.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 111.639 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 0.1 OUTLIER -88.52 170.36 10.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.578 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 2.0 tt0 -159.98 113.6 2.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.754 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.24 169.09 1.64 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.664 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.55 42.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.27 44.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.245 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.481 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -99.26 156.77 16.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.981 0.39 . . . . 0.0 110.736 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.21 144.24 2.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.34 89.47 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.027 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.12 157.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 0.0 112.281 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.723 ' CZ3' HD21 ' A' ' 117' ' ' LEU . 1.4 m-90 -133.07 149.06 52.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.663 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -106.73 111.67 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.119 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 11' ' ' TYR . 27.3 m -151.0 -179.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.508 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -153.58 111.95 3.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.718 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -54.77 143.18 51.59 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.902 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HG3' ' CZ3' ' A' ' 9' ' ' TRP . 58.7 Cg_endo -73.53 -52.65 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.49 2.126 . . . . 0.0 113.014 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 47' ' ' THR . 20.7 t -115.35 159.99 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.835 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 47' ' ' THR . 1.1 m -86.88 88.26 7.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.733 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.49 -137.11 2.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.603 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 3.9 tt0 -129.05 137.43 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.507 ' CD1' HD22 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -124.74 159.45 30.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.768 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 110.32 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 mm -84.11 119.45 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.464 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -109.8 124.37 51.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.472 ' HG ' ' HE2' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.44 124.91 45.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.17 0.51 . . . . 0.0 110.944 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 4.0 m -117.04 132.73 56.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.566 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -146.03 161.81 39.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.805 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.4 p -160.4 72.26 0.47 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.099 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -111.1 90.83 12.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.642 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 82' ' ' THR . 51.3 Cg_exo -53.73 81.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.935 1.757 . . . . 0.0 112.594 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 58' ' ' SER . 7.1 t80 -176.12 -115.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.433 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.476 ' N ' ' HB2' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 179.11 146.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.354 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 79' ' ' ALA . 11.6 p -140.73 -135.14 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 62' ' ' SER . 6.6 mtmt -165.56 174.2 10.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 21.6 t -38.12 140.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.605 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -148.6 169.25 20.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -88.46 137.6 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.48 ' CD1' ' HE2' ' A' ' 69' ' ' MET . 13.1 tp -118.85 109.98 16.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.016 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 22.7 t -85.65 99.08 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.567 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.48 ' HE2' ' CD1' ' A' ' 67' ' ' LEU . 37.1 mtt -131.26 106.75 8.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.126 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 69' ' ' MET . 43.5 t0 90.18 24.03 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.89 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.08 17.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.823 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 149.35 23.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.19 108.86 20.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -87.86 144.4 26.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.131 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -82.25 131.5 35.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -160.02 151.25 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.77 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.5 122.73 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.15 139.36 51.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.476 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HA ' ' OG ' ' A' ' 62' ' ' SER . . . -124.45 168.4 13.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.355 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.582 ' HG2' ' CB ' ' A' ' 58' ' ' SER . 14.3 mt-10 -95.99 88.18 4.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -94.98 142.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.895 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -81.21 -31.63 33.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.735 0.302 . . . . 0.0 111.42 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 85' ' ' VAL . 74.3 t -79.4 132.89 61.01 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.562 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.0 81.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.47 2.113 . . . . 0.0 111.857 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 83' ' ' VAL . 22.3 t -79.73 132.82 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.006 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 1.7 p -112.62 146.51 38.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 41.7 t80 -141.9 109.77 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.601 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.62 145.86 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.749 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.34 112.84 5.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.31 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -83.94 117.63 23.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.939 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' NZ ' ' HB2' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -144.41 156.2 44.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -94.83 125.87 39.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.085 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.951 178.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.86 147.54 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.07 0.462 . . . . 0.0 111.228 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.67 134.56 35.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.236 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.86 -156.55 25.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.559 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 116.97 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -136.18 136.55 40.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 m -95.91 146.88 24.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.472 ' CE2' HD12 ' A' ' 119' ' ' LEU . 7.6 m-85 -139.39 159.07 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 111.213 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 40' ' ' TRP . . . 154.92 -154.41 25.5 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.079 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -136.42 118.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 110.488 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.73 160.75 14.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.43 0.633 . . . . 0.0 112.361 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.467 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 41.5 t -130.21 108.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.53 -176.95 19.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.8 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -67.55 -41.47 84.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.11 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.795 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -143.83 96.82 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -118.39 137.93 52.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 95.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.589 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -37.94 132.28 0.98 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.311 0.244 . . . . 0.0 111.361 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 8.2 ptm -157.11 157.26 34.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -80.64 155.98 26.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.514 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 29' ' ' GLY . 48.2 t -139.55 96.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 2.2 t60 -69.22 -56.3 8.0 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 p -177.96 159.92 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.716 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.723 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 1.6 mm? -106.9 97.79 7.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -85.21 130.23 34.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.268 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.472 HD12 ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -130.03 107.74 9.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.051 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 1.5 tt0 -105.97 167.2 9.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 111.615 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD21 ' CE2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -81.09 54.44 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.644 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.898 -179.675 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CE3' ' N ' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.522 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' CB ' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.477 HD13 HD21 ' A' ' 24' ' ' LEU . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 28' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 8.5 p30 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.513 ' O ' HG11 ' A' ' 25' ' ' VAL . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.455 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' CG1' ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.448 ' CG1' ' HG ' ' A' ' 119' ' ' LEU . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.475 ' CD2' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.498 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.479 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.526 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 101' ' ' GLY . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.405 ' HE3' ' HG ' ' A' ' 54' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.412 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 70' ' ' ASP . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' CG2' HG23 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.426 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 3.0 m120 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' CG2' ' A' ' 102' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.494 HD11 ' HA3' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.448 ' HG ' ' CG1' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CE3' ' N ' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.522 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' CB ' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.477 HD13 HD21 ' A' ' 24' ' ' LEU . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 28' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 8.5 p30 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.513 ' O ' HG11 ' A' ' 25' ' ' VAL . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.455 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' CG1' ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.448 ' CG1' ' HG ' ' A' ' 119' ' ' LEU . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.475 ' CD2' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.498 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.479 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.526 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 101' ' ' GLY . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.405 ' HE3' ' HG ' ' A' ' 54' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.412 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 70' ' ' ASP . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' CG2' HG23 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.426 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 3.0 m120 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' CG2' ' A' ' 102' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.494 HD11 ' HA3' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.448 ' HG ' ' CG1' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.47 74.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.563 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.437 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 11.2 m-90 -104.46 104.75 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -98.63 98.59 9.72 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 178.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.525 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -80.67 94.95 6.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.958 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 155.43 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.806 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -72.09 -19.49 61.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.91 -13.5 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.82 -24.13 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.976 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . . . -79.92 -176.38 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.5 p -107.79 114.36 28.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mm -85.54 114.13 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -96.46 116.21 28.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.33 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.54 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -46.96 151.45 1.13 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.028 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 36' ' ' SER . 55.5 Cg_endo -67.02 3.33 2.38 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.044 -1.232 . . . . 0.0 113.409 0.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.54 ' N ' ' HA ' ' A' ' 20' ' ' ALA . . . -59.59 139.79 56.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.019 0.437 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.1 147.1 45.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -91.27 101.05 13.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.773 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 24.7 m -100.54 98.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.857 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.55 60.48 8.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.262 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 1.0 OUTLIER 58.01 21.65 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.831 0.348 . . . . 0.0 110.903 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 t -127.91 118.64 49.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -67.15 149.89 51.45 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.172 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.7 mm-40 -140.06 158.67 43.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 112' ' ' MET . 0.0 OUTLIER -145.17 153.21 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.309 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 11.1 mt-30 -151.32 92.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 111.094 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.05 -173.52 34.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.388 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.36 146.9 34.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.16 -24.74 25.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.003 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -82.06 151.24 27.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.861 0.33 . . . . 0.0 110.433 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.04 133.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -108.67 89.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.984 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -92.89 153.36 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.209 0.528 . . . . 0.0 112.146 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 1.4 m-90 -125.47 148.65 48.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.752 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -119.5 111.71 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.613 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.1 m -157.66 -179.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.194 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -124.99 137.74 54.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 98' ' ' HIS . 87.4 t -59.96 138.63 90.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.437 ' HG3' ' CH2' ' A' ' 9' ' ' TRP . 33.7 Cg_endo -65.32 -56.12 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.525 2.15 . . . . 0.0 112.583 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.45 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 0.0 111.802 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.6 p -107.85 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.9 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.23 -157.49 9.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 35.1 tt0 -110.33 123.2 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.489 ' CD2' ' CD1' ' A' ' 93' ' ' LEU . 3.7 m-85 -123.45 146.88 47.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -88.71 119.04 28.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 HD12 ' HD3' ' A' ' 91' ' ' LYS . 5.3 mt -78.95 146.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 2.2 m-20 -138.77 112.8 8.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.406 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.562 ' HG ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.41 118.72 36.65 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.134 0.492 . . . . 0.0 110.328 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.5 m -105.13 129.23 53.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.145 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.551 ' HZ3' ' O ' ' A' ' 79' ' ' ALA . 1.6 p-90 -160.03 148.72 17.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 81' ' ' ALA . 0.9 OUTLIER -161.24 109.32 1.52 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.659 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 10.0 m -154.0 84.68 4.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 52.6 Cg_exo -56.13 85.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.574 2.182 . . . . 0.0 112.078 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -117.38 -92.89 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.665 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -139.41 -106.52 0.17 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 12.8 t -175.8 144.23 0.62 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.898 0.38 . . . . 0.0 111.582 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 169.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.855 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.76 160.33 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.845 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -159.56 166.46 30.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.31 136.96 47.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.764 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 102' ' ' VAL . 12.5 tp -118.12 103.87 10.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 11.1 t -85.95 110.04 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.562 ' HE3' ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -126.3 101.21 6.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.489 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' HB2' ' CE ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER 78.58 32.81 0.3 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.869 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.0 16.89 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.937 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 128.42 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . . . -98.0 99.03 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.22 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -80.34 131.32 35.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.74 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.5 t -79.81 105.97 11.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.012 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 3.5 t80 -127.34 120.04 27.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.472 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.52 141.99 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.545 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -169.94 -93.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.149 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.551 ' O ' ' HZ3' ' A' ' 56' ' ' TRP . . . -169.15 -153.92 0.12 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.417 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.486 ' HG2' ' CB ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -104.96 32.39 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.253 0.549 . . . . 0.0 109.711 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.532 ' CB ' ' CE3' ' A' ' 56' ' ' TRP . . . 47.46 -168.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.949 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.467 ' OG1' ' HG3' ' A' ' 59' ' ' PRO . 2.4 t -160.4 -41.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.028 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -118.36 -175.85 0.35 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.857 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' N ' HG21 ' A' ' 83' ' ' VAL . 14.5 Cg_exo -67.22 63.0 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.523 1.482 . . . . 0.0 109.813 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 83' ' ' VAL . 26.0 t -79.34 113.51 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.064 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 60.4 p -97.69 156.14 16.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.507 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.47 ' CG ' ' OE1' ' A' ' 89' ' ' GLN . 5.7 t80 -129.18 129.07 44.6 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.51 134.69 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 112.123 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.47 ' OE1' ' CG ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -144.25 112.29 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.747 178.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p -80.27 117.51 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD3' HD12 ' A' ' 52' ' ' ILE . 3.1 ttpt -155.58 145.51 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 3.9 p -94.95 146.06 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.474 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.489 ' CD1' ' CD2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -124.87 143.96 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.45 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -95.44 163.14 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.612 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.78 122.03 24.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.169 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.76 -148.05 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.07 144.54 26.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.42 ' CE1' HG22 ' A' ' 44' ' ' VAL . 73.4 m80 -154.53 147.03 24.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 p -96.74 144.72 26.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.689 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -142.24 170.16 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.255 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' HA3' HD12 ' A' ' 117' ' ' LEU . . . 137.09 170.49 11.92 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.62 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -119.19 112.77 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 -179.43 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.375 0.607 . . . . 0.0 112.425 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.9 t -146.36 122.78 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.1 -170.32 12.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -32.34 69.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.935 0.398 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -65.64 -28.15 68.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.735 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -153.82 67.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -68.51 154.16 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.34 -170.62 25.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.46 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -123.36 150.86 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.056 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.475 ' HG2' ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -163.86 145.42 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.659 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 8.8 t-20 -80.93 170.47 16.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.603 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 29' ' ' GLY . 57.1 t -154.4 106.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.083 0.468 . . . . 0.0 110.773 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 116' ' ' SER . 37.7 t-80 -87.44 -55.45 3.79 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.565 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 3.4 t -177.0 137.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.52 ' CD1' ' CZ3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -87.06 111.56 21.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.808 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' TRP . 0.4 OUTLIER -120.16 130.3 54.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.501 . . . . 0.0 112.291 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.69 107.78 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.301 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -99.53 151.58 20.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.019 0.437 . . . . 0.0 111.877 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.3 138.87 58.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.736 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 7.3 mt -95.35 28.21 3.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.743 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.516 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -123.59 135.88 54.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.442 . . . . 0.0 111.673 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 160.27 15.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.252 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -137.78 94.72 2.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.962 0.411 . . . . 0.0 110.746 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 p -70.45 142.59 51.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.387 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.77 -19.77 64.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.597 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -30.82 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -104.86 29.92 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . . . -123.68 -165.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.7 m -114.02 104.09 11.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.41 HD11 HG11 ' A' ' 38' ' ' VAL . 1.5 mm -85.43 95.24 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.4 m -79.95 120.59 24.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.566 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -52.04 155.29 3.32 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.856 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 36' ' ' SER . 56.0 Cg_endo -67.99 4.86 2.49 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.985 -1.256 . . . . 0.0 113.316 0.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.566 ' N ' ' HA ' ' A' ' 20' ' ' ALA . . . -59.57 142.01 53.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 110.52 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -137.64 145.05 42.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -91.68 95.5 9.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 11.5 m -94.61 98.76 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.053 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.49 59.96 9.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.577 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 0.6 OUTLIER 59.72 20.72 9.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.717 0.294 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 114' ' ' VAL . 1.6 t -131.91 122.96 50.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD1' ' A' ' 113' ' ' ASN . . . -67.22 147.83 49.49 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.203 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 5.2 mt-10 -144.48 105.0 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 111.259 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 0.3 OUTLIER -88.65 159.67 17.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.125 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -154.81 87.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.821 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.2 175.1 45.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.364 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.01 151.05 43.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.08 -27.99 15.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.813 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.551 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.57 151.59 37.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.508 0.194 . . . . 0.0 110.483 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.15 107.13 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -89.25 89.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.6 mm -95.39 157.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 112.523 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.502 ' CZ3' HD11 ' A' ' 117' ' ' LEU . 4.6 m-90 -130.86 146.5 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.365 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.18 111.9 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.82 -176.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.88 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.65 135.7 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.399 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.3 t -69.24 130.1 91.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.569 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.516 ' HG3' ' CH2' ' A' ' 9' ' ' TRP . 71.9 Cg_endo -76.92 -45.01 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.343 2.029 . . . . 0.0 113.033 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.28 163.67 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 111.881 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.1 p -94.79 72.28 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.26 -132.62 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.802 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 37.0 tt0 -132.16 149.42 52.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.954 0.407 . . . . 0.0 111.227 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.477 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 20.5 m-85 -137.57 160.83 38.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.232 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.548 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.25 128.27 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.746 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -99.13 149.05 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.42 119.44 7.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -99.58 123.86 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 133.78 51.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.266 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.547 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -157.9 154.54 28.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.342 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.82 81.19 0.57 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -116.44 90.68 31.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.488 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 31.3 Cg_exo -61.59 61.58 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.215 1.944 . . . . 0.0 113.504 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -166.81 -88.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.481 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -45.19 174.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 45.5 m -173.94 105.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.778 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -171.16 161.45 6.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.871 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 12.0 t -56.53 163.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 112' ' ' MET . 24.3 t-20 -160.86 161.5 31.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.039 0.447 . . . . 0.0 111.433 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.12 137.19 41.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.467 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -108.49 107.61 18.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -91.06 96.85 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.953 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.45 ' HB3' ' CD1' ' A' ' 52' ' ' ILE . 4.4 mmt -132.95 114.4 13.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.432 ' N ' ' CE1' ' A' ' 100' ' ' PHE . 20.4 t0 65.55 41.69 4.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.1 26.07 71.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -128.64 122.88 31.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.43 93.89 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 1.4 pp -83.21 127.45 33.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.045 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.1 t -79.91 122.14 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -155.71 151.27 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.44 125.86 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.139 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' CD2' ' CZ2' ' A' ' 56' ' ' TRP . 8.3 m-85 -133.88 94.99 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.831 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 62' ' ' SER . . . -86.79 132.14 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.607 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.5 OUTLIER -51.45 88.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.68 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.64 161.47 29.66 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.262 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.488 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -103.21 -33.96 9.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.947 0.403 . . . . 0.0 110.995 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' VAL . 49.5 t -79.89 136.09 54.91 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.328 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.27 82.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.347 2.031 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 83' ' ' VAL . 23.1 t -84.05 139.5 17.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.32 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -122.54 114.3 20.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.973 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -93.73 105.66 17.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 38.3 t -79.93 129.52 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 4.7 mt-30 -144.22 127.76 17.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.2 p -104.8 137.28 42.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.933 0.397 . . . . 0.0 111.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HD2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.83 156.53 25.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.312 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -92.34 134.58 34.78 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.898 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.477 ' CD2' ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.48 144.36 51.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.902 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 p -102.58 143.69 31.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.83 122.05 6.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.371 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.08 -155.86 26.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.8 129.29 41.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -144.2 135.92 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -88.12 128.79 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CE1' ' N ' ' A' ' 70' ' ' ASP . 27.2 m-85 -128.42 147.39 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.33 -155.4 26.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.194 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -144.07 122.89 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.713 -0.244 . . . . 0.0 110.447 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.6 173.22 10.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.154 0.502 . . . . 0.0 111.894 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.421 ' CG1' ' HA ' ' A' ' 109' ' ' TRP . 47.0 t -126.89 128.28 70.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.659 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.43 -170.96 14.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.792 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -59.51 -37.43 78.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -62.06 -28.99 69.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.8 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -158.1 88.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.421 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -90.05 145.65 24.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.895 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.25 170.52 18.25 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.814 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.79 149.24 22.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.441 ' CE ' ' O ' ' A' ' 113' ' ' ASN . 3.9 tpt -164.41 130.04 2.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.662 0.268 . . . . 0.0 111.174 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.564 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 26.8 t30 -80.78 172.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 38' ' ' VAL . 11.0 t -153.85 119.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.1 OUTLIER -96.82 -58.94 1.91 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.99 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -179.41 144.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.502 HD11 ' CZ3' ' A' ' 40' ' ' TRP . 8.1 mp -88.31 159.84 17.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 9.6 tppt? -136.29 140.57 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -150.0 107.94 3.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.15 178.29 5.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.193 0.52 . . . . 0.0 111.752 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.435 HD23 ' CE1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -77.95 59.48 2.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.091 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . 6.0 mp 43.09 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.519 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.446 ' CZ3' ' HG3' ' A' ' 45' ' ' PRO . 20.0 m-90 -158.46 106.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.476 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.31 148.71 23.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.276 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CB ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -124.83 100.75 6.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.653 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -66.85 148.9 51.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.52 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 24' ' ' LEU . . . -63.15 -24.08 67.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.498 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.82 -24.71 63.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 94.1 p -107.31 29.53 7.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.765 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . . . -124.6 -165.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.75 104.21 12.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.516 HD12 HD22 ' A' ' 24' ' ' LEU . 15.6 mm -79.79 98.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.3 m -83.8 115.96 22.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.194 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -51.65 154.0 3.69 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 36' ' ' SER . 53.0 Cg_endo -66.82 1.94 2.58 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.11 -1.204 . . . . 0.0 113.472 0.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.534 ' N ' ' HA ' ' A' ' 20' ' ' ALA . . . -59.4 141.66 54.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -141.65 144.61 34.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.539 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD22 HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.93 91.04 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.782 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 28' ' ' VAL . 5.2 m -90.38 109.34 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.742 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.63 55.51 28.31 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.684 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 3.7 m120 58.49 20.88 7.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.195 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' VAL . 3.6 t -134.61 144.55 34.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.232 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' VAL . . . -78.5 143.17 26.7 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.762 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.8 OUTLIER -144.15 110.76 5.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 111.639 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 0.1 OUTLIER -88.52 170.36 10.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.578 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 2.0 tt0 -159.98 113.6 2.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.754 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.24 169.09 1.64 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.664 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.55 42.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.27 44.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.245 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.481 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -99.26 156.77 16.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.981 0.39 . . . . 0.0 110.736 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.21 144.24 2.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 HG22 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.34 89.47 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.027 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.12 157.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 0.0 112.281 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.723 ' CZ3' HD21 ' A' ' 117' ' ' LEU . 1.4 m-90 -133.07 149.06 52.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.663 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -106.73 111.67 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.119 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 11' ' ' TYR . 27.3 m -151.0 -179.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.508 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -153.58 111.95 3.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.718 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -54.77 143.18 51.59 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.902 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HG3' ' CZ3' ' A' ' 9' ' ' TRP . 58.7 Cg_endo -73.53 -52.65 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.49 2.126 . . . . 0.0 113.014 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 47' ' ' THR . 20.7 t -115.35 159.99 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.835 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 47' ' ' THR . 1.1 m -86.88 88.26 7.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.733 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.49 -137.11 2.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.603 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 3.9 tt0 -129.05 137.43 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.507 ' CD1' HD22 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -124.74 159.45 30.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.768 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 110.32 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 mm -84.11 119.45 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.464 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -109.8 124.37 51.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.472 ' HG ' ' HE2' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.44 124.91 45.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.17 0.51 . . . . 0.0 110.944 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 4.0 m -117.04 132.73 56.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.566 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -146.03 161.81 39.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.805 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.4 p -160.4 72.26 0.47 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.099 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -111.1 90.83 12.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.642 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 82' ' ' THR . 51.3 Cg_exo -53.73 81.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.935 1.757 . . . . 0.0 112.594 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 58' ' ' SER . 7.1 t80 -176.12 -115.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.433 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.476 ' N ' ' HB2' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 179.11 146.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.354 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 79' ' ' ALA . 11.6 p -140.73 -135.14 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 62' ' ' SER . 6.6 mtmt -165.56 174.2 10.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 21.6 t -38.12 140.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.605 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -148.6 169.25 20.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -88.46 137.6 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.48 ' CD1' ' HE2' ' A' ' 69' ' ' MET . 13.1 tp -118.85 109.98 16.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.016 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 22.7 t -85.65 99.08 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.567 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.48 ' HE2' ' CD1' ' A' ' 67' ' ' LEU . 37.1 mtt -131.26 106.75 8.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.126 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 69' ' ' MET . 43.5 t0 90.18 24.03 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.89 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.08 17.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.823 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 149.35 23.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.19 108.86 20.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -87.86 144.4 26.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.131 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -82.25 131.5 35.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -160.02 151.25 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.77 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.5 122.73 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.15 139.36 51.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.476 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HA ' ' OG ' ' A' ' 62' ' ' SER . . . -124.45 168.4 13.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.355 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.582 ' HG2' ' CB ' ' A' ' 58' ' ' SER . 14.3 mt-10 -95.99 88.18 4.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -94.98 142.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.895 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -81.21 -31.63 33.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.735 0.302 . . . . 0.0 111.42 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 85' ' ' VAL . 74.3 t -79.4 132.89 61.01 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.562 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.0 81.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.47 2.113 . . . . 0.0 111.857 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 83' ' ' VAL . 22.3 t -79.73 132.82 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.006 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 1.7 p -112.62 146.51 38.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 41.7 t80 -141.9 109.77 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.601 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.62 145.86 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.749 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.34 112.84 5.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.31 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -83.94 117.63 23.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.939 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' NZ ' ' HB2' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -144.41 156.2 44.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -94.83 125.87 39.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.085 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.951 178.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.86 147.54 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.07 0.462 . . . . 0.0 111.228 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.67 134.56 35.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.236 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.86 -156.55 25.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.559 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 116.97 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -136.18 136.55 40.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 m -95.91 146.88 24.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.472 ' CE2' HD12 ' A' ' 119' ' ' LEU . 7.6 m-85 -139.39 159.07 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 111.213 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 40' ' ' TRP . . . 154.92 -154.41 25.5 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.079 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -136.42 118.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 110.488 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.73 160.75 14.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.43 0.633 . . . . 0.0 112.361 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.467 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 41.5 t -130.21 108.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.53 -176.95 19.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.8 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -67.55 -41.47 84.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.11 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.795 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -143.83 96.82 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -118.39 137.93 52.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 95.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.589 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -37.94 132.28 0.98 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.311 0.244 . . . . 0.0 111.361 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 8.2 ptm -157.11 157.26 34.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -80.64 155.98 26.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.514 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 29' ' ' GLY . 48.2 t -139.55 96.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 2.2 t60 -69.22 -56.3 8.0 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 p -177.96 159.92 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.716 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.723 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 1.6 mm? -106.9 97.79 7.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -85.21 130.23 34.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.268 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.472 HD12 ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -130.03 107.74 9.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.051 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 1.5 tt0 -105.97 167.2 9.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 111.615 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD21 ' CE2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -81.09 54.44 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.644 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mt 57.65 178.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.898 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CE3' ' N ' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.522 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' CB ' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.477 HD13 HD21 ' A' ' 24' ' ' LEU . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 28' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 8.5 p30 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.513 ' O ' HG11 ' A' ' 25' ' ' VAL . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.455 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' CG1' ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.448 ' CG1' ' HG ' ' A' ' 119' ' ' LEU . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.475 ' CD2' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.498 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.479 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.701 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.526 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 101' ' ' GLY . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.405 ' HE3' ' HG ' ' A' ' 54' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 100' ' ' PHE . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.412 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 70' ' ' ASP . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' CG2' HG23 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.426 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' A' ' 30' ' ' GLU . 3.0 m120 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' CG2' ' A' ' 102' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.494 HD11 ' HA3' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.448 ' HG ' ' CG1' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.47 74.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.563 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.791 HG23 ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.956 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.753 HD13 HG12 ' A' ' 38' ' ' VAL . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.669 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' GLY . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ASN . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' O ' HG21 ' A' ' 104' ' ' VAL . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.956 ' CE2' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.73 HG11 ' CE2' ' A' ' 11' ' ' TYR . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' O ' HD12 ' A' ' 122' ' ' LEU . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 44' ' ' VAL . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' CD ' ' A' ' 91' ' ' LYS . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.753 ' HG ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.506 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.817 HD13 HG13 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 103' ' ' ARG . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.852 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.592 ' CG ' HD12 ' A' ' 93' ' ' LEU . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 85' ' ' VAL . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 83' ' ' VAL . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 83' ' ' VAL . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.842 ' C ' HD13 ' A' ' 93' ' ' LEU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.407 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.407 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 10.4 m-70 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 117' ' ' LEU . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.532 ' HA2' HD13 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.817 HG13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG2' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.766 HG13 ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.688 ' HB3' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.766 ' HA ' HG13 ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.635 ' SD ' HG23 ' A' ' 114' ' ' VAL . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.629 ' HB3' HG12 ' A' ' 28' ' ' VAL . 36.7 m-20 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 38' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.541 ' N ' HG13 ' A' ' 28' ' ' VAL . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.852 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.791 ' HG2' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.446 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 11.2 m-90 -104.46 104.75 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -98.63 98.59 9.72 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 178.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.552 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -80.67 94.95 6.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.958 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 155.43 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.806 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' CB ' HD21 ' A' ' 24' ' ' LEU . . . -72.09 -19.49 61.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.548 ' HB2' ' CG ' ' A' ' 27' ' ' ASN . . . -69.91 -13.5 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.82 -24.13 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.976 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.877 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . . . -79.92 -176.38 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.5 p -107.79 114.36 28.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.734 HD12 HG12 ' A' ' 38' ' ' VAL . 4.3 mm -85.54 114.13 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -96.46 116.21 28.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.33 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.564 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -46.96 151.45 1.13 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.028 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 36' ' ' SER . 55.5 Cg_endo -67.02 3.33 2.38 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.044 -1.232 . . . . 0.0 113.409 0.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.59 139.79 56.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.019 0.437 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.1 147.1 45.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.709 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -91.27 101.05 13.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.773 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 25' ' ' VAL . 24.7 m -100.54 98.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.857 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.672 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 60.55 60.48 8.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.262 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.709 ' HA ' HD11 ' A' ' 24' ' ' LEU . 1.0 OUTLIER 58.01 21.65 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.831 0.348 . . . . 0.0 110.903 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 26' ' ' GLY . 34.8 t -127.91 118.64 49.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' HG11 ' A' ' 38' ' ' VAL . . . -67.15 149.89 51.45 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.172 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.7 mm-40 -140.06 158.67 43.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.538 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -145.17 153.21 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.309 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 11.1 mt-30 -151.32 92.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 111.094 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.05 -173.52 34.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.388 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.36 146.9 34.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.16 -24.74 25.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.003 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -82.06 151.24 27.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.861 0.33 . . . . 0.0 110.433 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . . . -170.04 133.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -108.67 89.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.984 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.824 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 50.4 mm -92.89 153.36 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.209 0.528 . . . . 0.0 112.146 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.877 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 1.4 m-90 -125.47 148.65 48.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.752 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.1 m-80 -119.5 111.71 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.613 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 41' ' ' ASN . 17.1 m -157.66 -179.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.194 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -124.99 137.74 54.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' ND1' ' A' ' 98' ' ' HIS . 87.4 t -59.96 138.63 90.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 44' ' ' VAL . 33.7 Cg_endo -65.32 -56.12 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.525 2.15 . . . . 0.0 112.583 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.45 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 0.0 111.802 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.657 HG23 ' HB2' ' A' ' 95' ' ' ALA . 20.6 p -107.85 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.23 -157.49 9.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HG2' HD12 ' A' ' 122' ' ' LEU . 35.1 tt0 -110.33 123.2 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.96 ' CD2' HD13 ' A' ' 93' ' ' LEU . 3.7 m-85 -123.45 146.88 47.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.554 ' HB3' HD21 ' A' ' 122' ' ' LEU . 6.5 ptt180 -88.71 119.04 28.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 91' ' ' LYS . 5.3 mt -78.95 146.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 2.2 m-20 -138.77 112.8 8.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.406 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HG ' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.41 118.72 36.65 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.134 0.492 . . . . 0.0 110.328 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.5 m -105.13 129.23 53.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.145 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.758 ' CE3' ' HB2' ' A' ' 81' ' ' ALA . 1.6 p-90 -160.03 148.72 17.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.24 109.32 1.52 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 10.0 m -154.0 84.68 4.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 52.6 Cg_exo -56.13 85.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.574 2.182 . . . . 0.0 112.078 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -117.38 -92.89 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.665 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -139.41 -106.52 0.17 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 12.8 t -175.8 144.23 0.62 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.898 0.38 . . . . 0.0 111.582 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 169.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.855 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 77' ' ' ALA . 17.2 t -83.76 160.33 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.845 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 64' ' ' VAL . 42.9 m-80 -159.56 166.46 30.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.741 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -108.31 136.96 47.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.764 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.04 HD23 HD11 ' A' ' 74' ' ' LEU . 12.5 tp -118.12 103.87 10.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 11.1 t -85.95 110.04 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.721 ' SD ' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -126.3 101.21 6.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.489 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' HB2' ' CE ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER 78.58 32.81 0.3 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.869 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.0 16.89 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.937 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 128.42 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -98.0 99.03 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.22 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.04 HD11 HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -80.34 131.32 35.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.74 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.5 t -79.81 105.97 11.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.012 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 3.5 t80 -127.34 120.04 27.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.472 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -105.52 141.99 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.545 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.551 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -169.94 -93.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.149 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' HZ3' ' A' ' 56' ' ' TRP . . . -169.15 -153.92 0.12 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.417 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.511 ' HG2' ' CB ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -104.96 32.39 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.253 0.549 . . . . 0.0 109.711 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.758 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . . . 47.46 -168.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.949 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.971 HG23 HG13 ' A' ' 83' ' ' VAL . 2.4 t -160.4 -41.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.028 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.971 HG13 HG23 ' A' ' 82' ' ' THR . 0.9 OUTLIER -118.36 -175.85 0.35 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.857 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' N ' HG23 ' A' ' 83' ' ' VAL . 14.5 Cg_exo -67.22 63.0 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.523 1.482 . . . . 0.0 109.813 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.514 ' CG2' HG22 ' A' ' 83' ' ' VAL . 26.0 t -79.34 113.51 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.064 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 60.4 p -97.69 156.14 16.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.507 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.624 ' CG ' ' NE2' ' A' ' 89' ' ' GLN . 5.7 t80 -129.18 129.07 44.6 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.51 134.69 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 112.123 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.624 ' NE2' ' CG ' ' A' ' 87' ' ' TYR . 8.2 mp0 -144.25 112.29 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.747 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.609 HG22 HD11 ' A' ' 122' ' ' LEU . 6.3 p -80.27 117.51 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.627 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.1 ttpt -155.58 145.51 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.501 HG22 ' CA ' ' A' ' 49' ' ' GLU . 3.9 p -94.95 146.06 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.474 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.96 HD13 ' CD2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -124.87 143.96 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.45 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -95.44 163.14 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.612 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.657 ' HB2' HG23 ' A' ' 47' ' ' THR . . . -76.78 122.03 24.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.76 -148.05 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.07 144.54 26.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.554 ' ND1' HG23 ' A' ' 44' ' ' VAL . 73.4 m80 -154.53 147.03 24.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 p -96.74 144.72 26.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.689 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.763 ' HB3' HD22 ' A' ' 117' ' ' LEU . 44.3 m-85 -142.24 170.16 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.255 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.09 170.49 11.92 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.62 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.661 ' H ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -119.19 112.77 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.543 ' HB2' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -116.22 -179.43 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.375 0.607 . . . . 0.0 112.425 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 108' ' ' ASP . 16.9 t -146.36 122.78 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.1 -170.32 12.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -32.34 69.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.935 0.398 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -65.64 -28.15 68.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.735 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.628 ' O ' HG13 ' A' ' 104' ' ' VAL . 19.5 m-20 -153.82 67.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.476 ' HA ' HG12 ' A' ' 104' ' ' VAL . 1.1 p90 -68.51 154.16 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' HG11 ' A' ' 104' ' ' VAL . . . 143.34 -170.62 25.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.46 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -123.36 150.86 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.056 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -163.86 145.42 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 8.8 t-20 -80.93 170.47 16.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.603 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 38' ' ' VAL . 57.1 t -154.4 106.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.083 0.468 . . . . 0.0 110.773 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 37.7 t-80 -87.44 -55.45 3.79 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.565 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.658 ' OG ' HG22 ' A' ' 10' ' ' THR . 3.4 t -177.0 137.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -87.06 111.56 21.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.808 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.703 ' HB3' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -120.16 130.3 54.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.501 . . . . 0.0 112.291 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.917 HD22 HD21 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.69 107.78 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.301 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -99.53 151.58 20.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.019 0.437 . . . . 0.0 111.877 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.517 HD13 ' CE1' ' A' ' 50' ' ' TYR . 1.1 mm? -65.3 138.87 58.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.736 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.628 HD12 ' HG2' ' A' ' 49' ' ' GLU . 7.3 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.743 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -123.59 135.88 54.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.442 . . . . 0.0 111.673 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 160.27 15.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.252 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.635 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -137.78 94.72 2.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.962 0.411 . . . . 0.0 110.746 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 p -70.45 142.59 51.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.387 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 114' ' ' VAL . . . -68.77 -19.77 64.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.597 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' A' ' 27' ' ' ASN . . . -69.87 -30.82 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -104.86 29.92 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . . . -123.68 -165.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.7 m -114.02 104.09 11.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.928 HD12 HG12 ' A' ' 38' ' ' VAL . 1.5 mm -85.43 95.24 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 70.4 m -79.95 120.59 24.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.589 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -52.04 155.29 3.32 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.856 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 36' ' ' SER . 56.0 Cg_endo -67.99 4.86 2.49 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.985 -1.256 . . . . 0.0 113.316 0.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.57 142.01 53.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 110.52 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -137.64 145.05 42.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -91.68 95.5 9.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 25' ' ' VAL . 11.5 m -94.61 98.76 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.053 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 60.49 59.96 9.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.577 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.751 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.6 OUTLIER 59.72 20.72 9.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.717 0.294 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 26' ' ' GLY . 1.6 t -131.91 122.96 50.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD1' ' A' ' 113' ' ' ASN . . . -67.22 147.83 49.49 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.203 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 25' ' ' VAL . 5.2 mt-10 -144.48 105.0 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 111.259 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 112' ' ' MET . 0.3 OUTLIER -88.65 159.67 17.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.125 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -154.81 87.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.821 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.2 175.1 45.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.364 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.01 151.05 43.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.08 -27.99 15.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.813 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.57 151.59 37.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.508 0.194 . . . . 0.0 110.483 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . . . -170.15 107.13 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -89.25 89.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 40' ' ' TRP . 17.6 mm -95.39 157.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 112.523 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.839 ' NE1' ' HB2' ' A' ' 16' ' ' ALA . 4.6 m-90 -130.86 146.5 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.365 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.18 111.9 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.635 HG11 ' CE2' ' A' ' 11' ' ' TYR . 17.2 m -149.82 -176.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.65 135.7 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.399 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.612 HG13 ' HE2' ' A' ' 50' ' ' TYR . 40.3 t -69.24 130.1 91.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.569 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HG3' ' CH2' ' A' ' 9' ' ' TRP . 71.9 Cg_endo -76.92 -45.01 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.343 2.029 . . . . 0.0 113.033 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.507 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -122.28 163.67 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 111.881 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 95' ' ' ALA . 41.1 p -94.79 72.28 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.26 -132.62 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.802 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.819 ' OE2' HD21 ' A' ' 122' ' ' LEU . 37.0 tt0 -132.16 149.42 52.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.954 0.407 . . . . 0.0 111.227 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.832 ' CD2' HD23 ' A' ' 93' ' ' LEU . 20.5 m-85 -137.57 160.83 38.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.232 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.573 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.25 128.27 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.746 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.679 HD12 ' CE ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -99.13 149.05 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' A' ' 86' ' ' THR . 0.1 OUTLIER -148.42 119.44 7.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.551 ' CD2' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.58 123.86 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 133.78 51.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.266 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.547 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -157.9 154.54 28.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.342 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -161.82 81.19 0.57 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -116.44 90.68 31.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.487 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 31.3 Cg_exo -61.59 61.58 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.215 1.944 . . . . 0.0 113.504 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -166.81 -88.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.5 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -45.19 174.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 45.5 m -173.94 105.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.778 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -171.16 161.45 6.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.871 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 65' ' ' ASN . 12.0 t -56.53 163.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.549 ' OD1' HG22 ' A' ' 104' ' ' VAL . 3.3 t30 -160.86 161.5 31.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.039 0.447 . . . . 0.0 111.433 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.573 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -103.12 137.19 41.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' CG1' ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.49 107.61 18.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -91.06 96.85 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.953 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.551 ' HE1' ' CD2' ' A' ' 54' ' ' LEU . 4.4 mmt -132.95 114.4 13.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.432 ' N ' ' CE1' ' A' ' 100' ' ' PHE . 20.4 t0 65.55 41.69 4.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.1 26.07 71.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -128.64 122.88 31.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -100.43 93.89 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 1.4 pp -83.21 127.45 33.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.045 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.1 t -79.91 122.14 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -155.71 151.27 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.44 125.86 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.139 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' CD2' ' CZ2' ' A' ' 56' ' ' TRP . 8.3 m-85 -133.88 94.99 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.831 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 62' ' ' SER . . . -86.79 132.14 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.607 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.543 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.5 OUTLIER -51.45 88.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.68 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.64 161.47 29.66 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.262 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.487 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -103.21 -33.96 9.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.947 0.403 . . . . 0.0 110.995 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 85' ' ' VAL . 49.5 t -79.89 136.09 54.91 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.328 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.27 82.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.347 2.031 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 83' ' ' VAL . 23.1 t -84.05 139.5 17.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.32 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.733 HG22 ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -122.54 114.3 20.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.973 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -93.73 105.66 17.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 38.3 t -79.93 129.52 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' HD21 ' A' ' 74' ' ' LEU . 4.7 mt-30 -144.22 127.76 17.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.2 p -104.8 137.28 42.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.933 0.397 . . . . 0.0 111.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.74 ' HG2' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.83 156.53 25.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.312 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.789 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -92.34 134.58 34.78 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.898 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.48 144.36 51.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.902 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 p -102.58 143.69 31.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' H ' HG22 ' A' ' 47' ' ' THR . . . -49.83 122.05 6.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.371 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.08 -155.86 26.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.8 129.29 41.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -144.2 135.92 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -88.12 128.79 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CE1' ' N ' ' A' ' 70' ' ' ASP . 27.2 m-85 -128.42 147.39 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' HA2' ' CZ3' ' A' ' 40' ' ' TRP . . . 159.33 -155.4 26.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.194 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.715 ' CG1' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -144.07 122.89 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.713 -0.244 . . . . 0.0 110.447 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -127.6 173.22 10.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.154 0.502 . . . . 0.0 111.894 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.549 HG22 ' OD1' ' A' ' 65' ' ' ASN . 47.0 t -126.89 128.28 70.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.659 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.43 -170.96 14.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.792 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -59.51 -37.43 78.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -62.06 -28.99 69.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.8 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -158.1 88.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.441 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -90.05 145.65 24.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.895 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.25 170.52 18.25 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.814 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.79 149.24 22.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.9 tpt -164.41 130.04 2.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.662 0.268 . . . . 0.0 111.174 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 26.8 t30 -80.78 172.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 38' ' ' VAL . 11.0 t -153.85 119.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.1 OUTLIER -96.82 -58.94 1.91 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.99 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -179.41 144.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.063 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.738 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 8.1 mp -88.31 159.84 17.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 9.6 tppt? -136.29 140.57 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -150.0 107.94 3.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.15 178.29 5.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.193 0.52 . . . . 0.0 111.752 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.95 59.48 2.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.091 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.819 HD21 ' OE2' ' A' ' 49' ' ' GLU . 6.0 mp . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.519 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.451 ' CZ3' ' HG3' ' A' ' 45' ' ' PRO . 20.0 m-90 -158.46 106.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.476 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.429 HG23 ' CB ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -98.31 148.71 23.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.276 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CB ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -124.83 100.75 6.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.653 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -66.85 148.9 51.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.52 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . -63.15 -24.08 67.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.498 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.82 -24.71 63.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 94.1 p -107.31 29.53 7.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.765 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.798 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . . . -124.6 -165.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.75 104.21 12.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.796 ' CD1' HD23 ' A' ' 24' ' ' LEU . 15.6 mm -79.79 98.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.624 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 60.3 m -83.8 115.96 22.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.194 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.556 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -51.65 154.0 3.69 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 36' ' ' SER . 53.0 Cg_endo -66.82 1.94 2.58 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.11 -1.204 . . . . 0.0 113.472 0.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.4 141.66 54.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.592 ' HA ' HG21 ' A' ' 18' ' ' ILE . 9.5 tt0 -141.65 144.61 34.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.539 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.796 HD23 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.93 91.04 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.782 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 25' ' ' VAL . 5.2 m -90.38 109.34 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.742 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 61.63 55.51 28.31 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.684 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 3.7 m120 58.49 20.88 7.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.195 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 26' ' ' GLY . 3.6 t -134.61 144.55 34.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.232 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' VAL . . . -78.5 143.17 26.7 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.762 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.8 OUTLIER -144.15 110.76 5.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 111.639 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.785 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -88.52 170.36 10.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.578 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 2.0 tt0 -159.98 113.6 2.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.754 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.24 169.09 1.64 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.664 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.55 42.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.27 44.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.245 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -99.26 156.77 16.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.981 0.39 . . . . 0.0 110.736 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -170.21 144.24 2.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.34 89.47 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.027 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.701 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 28.4 mm -90.12 157.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 0.0 112.281 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.802 ' CZ3' HD23 ' A' ' 117' ' ' LEU . 1.4 m-90 -133.07 149.06 52.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.663 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -106.73 111.67 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.119 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.442 HG11 ' CE1' ' A' ' 11' ' ' TYR . 27.3 m -151.0 -179.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.508 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -153.58 111.95 3.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.718 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 95' ' ' ALA . 2.4 m -54.77 143.18 51.59 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.902 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 9' ' ' TRP . 58.7 Cg_endo -73.53 -52.65 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.49 2.126 . . . . 0.0 113.014 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 47' ' ' THR . 20.7 t -115.35 159.99 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.835 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 47' ' ' THR . 1.1 m -86.88 88.26 7.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.733 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.49 -137.11 2.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.603 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.758 ' OE1' HD11 ' A' ' 122' ' ' LEU . 3.9 tt0 -129.05 137.43 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.675 ' CD1' HD23 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -124.74 159.45 30.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.768 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 110.32 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 52' ' ' ILE . 1.1 mm -84.11 119.45 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.464 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -109.8 124.37 51.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.513 ' HG ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.44 124.91 45.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.17 0.51 . . . . 0.0 110.944 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 4.0 m -117.04 132.73 56.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.566 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.485 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -146.03 161.81 39.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.805 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.4 p -160.4 72.26 0.47 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.099 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -111.1 90.83 12.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.642 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.468 ' CA ' ' HB ' ' A' ' 82' ' ' THR . 51.3 Cg_exo -53.73 81.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.935 1.757 . . . . 0.0 112.594 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 58' ' ' SER . 7.1 t80 -176.12 -115.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.433 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.504 ' N ' ' HB2' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 179.11 146.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.354 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.518 ' OG ' ' HA ' ' A' ' 79' ' ' ALA . 11.6 p -140.73 -135.14 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 62' ' ' SER . 6.6 mtmt -165.56 174.2 10.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 21.6 t -38.12 140.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.605 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.567 ' OD1' HG22 ' A' ' 104' ' ' VAL . 1.6 t-20 -148.6 169.25 20.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.967 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.46 137.6 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.861 HD13 HG13 ' A' ' 102' ' ' VAL . 13.1 tp -118.85 109.98 16.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.016 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 22.7 t -85.65 99.08 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.567 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.795 ' HE3' HD11 ' A' ' 67' ' ' LEU . 37.1 mtt -131.26 106.75 8.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.126 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.613 ' CG ' HD12 ' A' ' 93' ' ' LEU . 43.5 t0 90.18 24.03 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.89 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.08 17.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.823 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 149.35 23.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -104.19 108.86 20.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.508 HD21 HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -87.86 144.4 26.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.131 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -82.25 131.5 35.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.408 ' O ' HG13 ' A' ' 64' ' ' VAL . 8.8 t80 -160.02 151.25 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.5 122.73 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.15 139.36 51.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.476 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' OG ' ' A' ' 62' ' ' SER . . . -124.45 168.4 13.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.355 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 14.3 mt-10 -95.99 88.18 4.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -94.98 142.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.895 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.468 ' HB ' ' CA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -81.21 -31.63 33.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.735 0.302 . . . . 0.0 111.42 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 85' ' ' VAL . 74.3 t -79.4 132.89 61.01 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.562 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.0 81.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.47 2.113 . . . . 0.0 111.857 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 83' ' ' VAL . 22.3 t -79.73 132.82 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.006 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 1.7 p -112.62 146.51 38.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 41.7 t80 -141.9 109.77 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.601 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.4 HG22 ' ND2' ' A' ' 53' ' ' ASN . 40.6 t -79.62 145.86 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.749 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.34 112.84 5.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.31 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -83.94 117.63 23.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.939 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HZ3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -144.41 156.2 44.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.8 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -94.83 125.87 39.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.085 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.951 178.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.86 147.54 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.07 0.462 . . . . 0.0 111.228 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 44' ' ' VAL . . . -52.67 134.56 35.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.236 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.86 -156.55 25.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.559 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 116.97 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -136.18 136.55 40.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 m -95.91 146.88 24.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.543 ' CE2' HD11 ' A' ' 119' ' ' LEU . 7.6 m-85 -139.39 159.07 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 111.213 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CZ3' ' A' ' 40' ' ' TRP . . . 154.92 -154.41 25.5 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.079 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.861 HG13 HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -136.42 118.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 110.488 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -100.73 160.75 14.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.43 0.633 . . . . 0.0 112.361 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.785 ' CG2' HD13 ' A' ' 31' ' ' LEU . 41.5 t -130.21 108.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.53 -176.95 19.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.8 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -67.55 -41.47 84.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.11 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.795 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -143.83 96.82 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -118.39 137.93 52.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 95.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.589 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -37.94 132.28 0.98 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.311 0.244 . . . . 0.0 111.361 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 8.2 ptm -157.11 157.26 34.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.515 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -80.64 155.98 26.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.514 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 38' ' ' VAL . 48.2 t -139.55 96.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.526 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 2.2 t60 -69.22 -56.3 8.0 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 p -177.96 159.92 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.716 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.802 HD23 ' CZ3' ' A' ' 40' ' ' TRP . 1.6 mm? -106.9 97.79 7.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CB ' HG23 ' A' ' 10' ' ' THR . 7.7 tttm -85.21 130.23 34.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.268 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.595 HD23 ' CB ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -130.03 107.74 9.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.051 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 1.5 tt0 -105.97 167.2 9.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 111.615 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.632 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -81.09 54.44 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.644 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.758 HD11 ' OE1' ' A' ' 49' ' ' GLU . 1.7 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.898 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.791 HG23 ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.956 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.753 HD13 HG12 ' A' ' 38' ' ' VAL . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.669 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' GLY . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ASN . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' O ' HG21 ' A' ' 104' ' ' VAL . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.956 ' CE2' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.73 HG11 ' CE2' ' A' ' 11' ' ' TYR . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' O ' HD12 ' A' ' 122' ' ' LEU . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 44' ' ' VAL . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' CD ' ' A' ' 91' ' ' LYS . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.753 ' HG ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.506 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.817 HD13 HG13 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 103' ' ' ARG . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.852 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.592 ' CG ' HD12 ' A' ' 93' ' ' LEU . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 85' ' ' VAL . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 83' ' ' VAL . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 83' ' ' VAL . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.842 ' C ' HD13 ' A' ' 93' ' ' LEU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.407 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.407 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 10.4 m-70 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 117' ' ' LEU . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.532 ' HA2' HD13 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.817 HG13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG2' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.766 HG13 ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.688 ' HB3' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.766 ' HA ' HG13 ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.635 ' SD ' HG23 ' A' ' 114' ' ' VAL . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.629 ' HB3' HG12 ' A' ' 28' ' ' VAL . 36.7 m-20 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 38' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.541 ' N ' HG13 ' A' ' 28' ' ' VAL . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.852 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.791 ' HG2' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.791 HG23 ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.956 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.753 HD13 HG12 ' A' ' 38' ' ' VAL . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.669 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' GLY . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ASN . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' O ' HG21 ' A' ' 104' ' ' VAL . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.956 ' CE2' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.73 HG11 ' CE2' ' A' ' 11' ' ' TYR . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' O ' HD12 ' A' ' 122' ' ' LEU . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 44' ' ' VAL . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' CD ' ' A' ' 91' ' ' LYS . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.753 ' HG ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.817 HD13 HG13 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 103' ' ' ARG . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.852 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.592 ' CG ' HD12 ' A' ' 93' ' ' LEU . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 85' ' ' VAL . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 83' ' ' VAL . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 83' ' ' VAL . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.842 ' C ' HD13 ' A' ' 93' ' ' LEU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.407 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.407 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 10.4 m-70 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 117' ' ' LEU . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.532 ' HA2' HD13 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.817 HG13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG2' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.766 HG13 ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.688 ' HB3' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.766 ' HA ' HG13 ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.635 ' SD ' HG23 ' A' ' 114' ' ' VAL . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.629 ' HB3' HG12 ' A' ' 28' ' ' VAL . 36.7 m-20 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 38' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.541 ' N ' HG13 ' A' ' 28' ' ' VAL . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.852 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.791 ' HG2' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER 54.47 74.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.563 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.446 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 11.2 m-90 -104.46 104.75 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -98.63 98.59 9.72 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 178.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.552 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -80.67 94.95 6.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.958 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 155.43 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.806 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' CB ' HD21 ' A' ' 24' ' ' LEU . . . -72.09 -19.49 61.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.548 ' HB2' ' CG ' ' A' ' 27' ' ' ASN . . . -69.91 -13.5 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.82 -24.13 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.976 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.877 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . . . -79.92 -176.38 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.5 p -107.79 114.36 28.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.734 HD12 HG12 ' A' ' 38' ' ' VAL . 4.3 mm -85.54 114.13 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -96.46 116.21 28.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.33 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.564 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -46.96 151.45 1.13 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.028 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 36' ' ' SER . 55.5 Cg_endo -67.02 3.33 2.38 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.044 -1.232 . . . . 0.0 113.409 0.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.59 139.79 56.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.019 0.437 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.1 147.1 45.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.709 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -91.27 101.05 13.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.773 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 25' ' ' VAL . 24.7 m -100.54 98.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.857 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.672 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 60.55 60.48 8.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.262 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.709 ' HA ' HD11 ' A' ' 24' ' ' LEU . 1.0 OUTLIER 58.01 21.65 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.831 0.348 . . . . 0.0 110.903 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 26' ' ' GLY . 34.8 t -127.91 118.64 49.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' HG11 ' A' ' 38' ' ' VAL . . . -67.15 149.89 51.45 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.172 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.7 mm-40 -140.06 158.67 43.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.538 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -145.17 153.21 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.309 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 11.1 mt-30 -151.32 92.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 111.094 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.05 -173.52 34.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.388 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.36 146.9 34.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.16 -24.74 25.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.003 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -82.06 151.24 27.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.861 0.33 . . . . 0.0 110.433 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . . . -170.04 133.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -108.67 89.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.984 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.824 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 50.4 mm -92.89 153.36 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.209 0.528 . . . . 0.0 112.146 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.877 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 1.4 m-90 -125.47 148.65 48.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.752 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.1 m-80 -119.5 111.71 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.613 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 41' ' ' ASN . 17.1 m -157.66 -179.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.194 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -124.99 137.74 54.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' ND1' ' A' ' 98' ' ' HIS . 87.4 t -59.96 138.63 90.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 44' ' ' VAL . 33.7 Cg_endo -65.32 -56.12 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.525 2.15 . . . . 0.0 112.583 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.45 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 0.0 111.802 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.657 HG23 ' HB2' ' A' ' 95' ' ' ALA . 20.6 p -107.85 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.23 -157.49 9.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HG2' HD12 ' A' ' 122' ' ' LEU . 35.1 tt0 -110.33 123.2 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.96 ' CD2' HD13 ' A' ' 93' ' ' LEU . 3.7 m-85 -123.45 146.88 47.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.554 ' HB3' HD21 ' A' ' 122' ' ' LEU . 6.5 ptt180 -88.71 119.04 28.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 91' ' ' LYS . 5.3 mt -78.95 146.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 2.2 m-20 -138.77 112.8 8.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.406 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HG ' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.41 118.72 36.65 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.134 0.492 . . . . 0.0 110.328 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.5 m -105.13 129.23 53.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.145 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.758 ' CE3' ' HB2' ' A' ' 81' ' ' ALA . 1.6 p-90 -160.03 148.72 17.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.24 109.32 1.52 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 10.0 m -154.0 84.68 4.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 52.6 Cg_exo -56.13 85.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.574 2.182 . . . . 0.0 112.078 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -117.38 -92.89 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.665 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -139.41 -106.52 0.17 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 12.8 t -175.8 144.23 0.62 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.898 0.38 . . . . 0.0 111.582 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 169.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.855 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 77' ' ' ALA . 17.2 t -83.76 160.33 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.845 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 64' ' ' VAL . 42.9 m-80 -159.56 166.46 30.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.741 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -108.31 136.96 47.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.764 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.04 HD23 HD11 ' A' ' 74' ' ' LEU . 12.5 tp -118.12 103.87 10.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 11.1 t -85.95 110.04 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.721 ' SD ' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -126.3 101.21 6.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.489 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' HB2' ' CE ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER 78.58 32.81 0.3 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.869 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.0 16.89 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.937 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 128.42 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -98.0 99.03 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.22 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.04 HD11 HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -80.34 131.32 35.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.74 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.5 t -79.81 105.97 11.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.012 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 3.5 t80 -127.34 120.04 27.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.472 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -105.52 141.99 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.545 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.551 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -169.94 -93.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.149 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' HZ3' ' A' ' 56' ' ' TRP . . . -169.15 -153.92 0.12 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.417 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.511 ' HG2' ' CB ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -104.96 32.39 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.253 0.549 . . . . 0.0 109.711 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.758 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . . . 47.46 -168.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.949 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.971 HG23 HG13 ' A' ' 83' ' ' VAL . 2.4 t -160.4 -41.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.028 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.971 HG13 HG23 ' A' ' 82' ' ' THR . 0.9 OUTLIER -118.36 -175.85 0.35 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.857 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' N ' HG23 ' A' ' 83' ' ' VAL . 14.5 Cg_exo -67.22 63.0 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.523 1.482 . . . . 0.0 109.813 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.514 ' CG2' HG22 ' A' ' 83' ' ' VAL . 26.0 t -79.34 113.51 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.064 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 60.4 p -97.69 156.14 16.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.507 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.624 ' CG ' ' NE2' ' A' ' 89' ' ' GLN . 5.7 t80 -129.18 129.07 44.6 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.51 134.69 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 112.123 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.624 ' NE2' ' CG ' ' A' ' 87' ' ' TYR . 8.2 mp0 -144.25 112.29 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.747 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.609 HG22 HD11 ' A' ' 122' ' ' LEU . 6.3 p -80.27 117.51 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.627 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.1 ttpt -155.58 145.51 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.501 HG22 ' CA ' ' A' ' 49' ' ' GLU . 3.9 p -94.95 146.06 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.474 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.96 HD13 ' CD2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -124.87 143.96 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.45 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -95.44 163.14 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.612 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.657 ' HB2' HG23 ' A' ' 47' ' ' THR . . . -76.78 122.03 24.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.76 -148.05 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.07 144.54 26.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.554 ' ND1' HG23 ' A' ' 44' ' ' VAL . 73.4 m80 -154.53 147.03 24.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 p -96.74 144.72 26.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.689 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.763 ' HB3' HD22 ' A' ' 117' ' ' LEU . 44.3 m-85 -142.24 170.16 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.255 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.09 170.49 11.92 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.62 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.661 ' H ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -119.19 112.77 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.543 ' HB2' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -116.22 -179.43 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.375 0.607 . . . . 0.0 112.425 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 108' ' ' ASP . 16.9 t -146.36 122.78 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.1 -170.32 12.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -32.34 69.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.935 0.398 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -65.64 -28.15 68.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.735 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.628 ' O ' HG13 ' A' ' 104' ' ' VAL . 19.5 m-20 -153.82 67.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.476 ' HA ' HG12 ' A' ' 104' ' ' VAL . 1.1 p90 -68.51 154.16 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' HG11 ' A' ' 104' ' ' VAL . . . 143.34 -170.62 25.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.46 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -123.36 150.86 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.056 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -163.86 145.42 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 8.8 t-20 -80.93 170.47 16.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.603 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 38' ' ' VAL . 57.1 t -154.4 106.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.083 0.468 . . . . 0.0 110.773 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 37.7 t-80 -87.44 -55.45 3.79 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.565 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.658 ' OG ' HG22 ' A' ' 10' ' ' THR . 3.4 t -177.0 137.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -87.06 111.56 21.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.808 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.703 ' HB3' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -120.16 130.3 54.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.501 . . . . 0.0 112.291 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.917 HD22 HD21 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.69 107.78 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.301 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -99.53 151.58 20.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.019 0.437 . . . . 0.0 111.877 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.517 HD13 ' CE1' ' A' ' 50' ' ' TYR . 1.1 mm? -65.3 138.87 58.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.736 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.628 HD12 ' HG2' ' A' ' 49' ' ' GLU . 7.3 mt -95.35 28.21 3.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.743 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -123.59 135.88 54.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.442 . . . . 0.0 111.673 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 160.27 15.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.252 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.635 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -137.78 94.72 2.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.962 0.411 . . . . 0.0 110.746 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 p -70.45 142.59 51.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.387 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 114' ' ' VAL . . . -68.77 -19.77 64.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.597 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' A' ' 27' ' ' ASN . . . -69.87 -30.82 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -104.86 29.92 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . . . -123.68 -165.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.7 m -114.02 104.09 11.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.928 HD12 HG12 ' A' ' 38' ' ' VAL . 1.5 mm -85.43 95.24 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 70.4 m -79.95 120.59 24.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.589 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -52.04 155.29 3.32 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.856 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 36' ' ' SER . 56.0 Cg_endo -67.99 4.86 2.49 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.985 -1.256 . . . . 0.0 113.316 0.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.57 142.01 53.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 110.52 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -137.64 145.05 42.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -91.68 95.5 9.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 25' ' ' VAL . 11.5 m -94.61 98.76 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.053 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 60.49 59.96 9.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.577 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.751 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.6 OUTLIER 59.72 20.72 9.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.717 0.294 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 26' ' ' GLY . 1.6 t -131.91 122.96 50.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD1' ' A' ' 113' ' ' ASN . . . -67.22 147.83 49.49 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.203 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 25' ' ' VAL . 5.2 mt-10 -144.48 105.0 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 111.259 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 112' ' ' MET . 0.3 OUTLIER -88.65 159.67 17.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.125 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -154.81 87.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.821 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.2 175.1 45.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.364 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.01 151.05 43.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.08 -27.99 15.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.813 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.57 151.59 37.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.508 0.194 . . . . 0.0 110.483 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . . . -170.15 107.13 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -89.25 89.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 40' ' ' TRP . 17.6 mm -95.39 157.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 112.523 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.839 ' NE1' ' HB2' ' A' ' 16' ' ' ALA . 4.6 m-90 -130.86 146.5 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.365 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.18 111.9 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG11 ' CE2' ' A' ' 11' ' ' TYR . 17.2 m -149.82 -176.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.65 135.7 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.399 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.612 HG13 ' HE2' ' A' ' 50' ' ' TYR . 40.3 t -69.24 130.1 91.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.569 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HG3' ' CH2' ' A' ' 9' ' ' TRP . 71.9 Cg_endo -76.92 -45.01 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.343 2.029 . . . . 0.0 113.033 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.507 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -122.28 163.67 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 111.881 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 95' ' ' ALA . 41.1 p -94.79 72.28 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.26 -132.62 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.802 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.819 ' OE2' HD21 ' A' ' 122' ' ' LEU . 37.0 tt0 -132.16 149.42 52.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.954 0.407 . . . . 0.0 111.227 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.832 ' CD2' HD23 ' A' ' 93' ' ' LEU . 20.5 m-85 -137.57 160.83 38.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.232 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.573 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.25 128.27 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.746 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.679 HD12 ' CE ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -99.13 149.05 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' A' ' 86' ' ' THR . 0.1 OUTLIER -148.42 119.44 7.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.551 ' CD2' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.58 123.86 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 133.78 51.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.266 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.547 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -157.9 154.54 28.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.342 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -161.82 81.19 0.57 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -116.44 90.68 31.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.487 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 31.3 Cg_exo -61.59 61.58 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.215 1.944 . . . . 0.0 113.504 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -166.81 -88.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.5 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -45.19 174.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 45.5 m -173.94 105.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.778 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -171.16 161.45 6.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.871 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 65' ' ' ASN . 12.0 t -56.53 163.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.549 ' OD1' HG22 ' A' ' 104' ' ' VAL . 3.3 t30 -160.86 161.5 31.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.039 0.447 . . . . 0.0 111.433 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.573 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -103.12 137.19 41.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' CG1' ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.49 107.61 18.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -91.06 96.85 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.953 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.551 ' HE1' ' CD2' ' A' ' 54' ' ' LEU . 4.4 mmt -132.95 114.4 13.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.432 ' N ' ' CE1' ' A' ' 100' ' ' PHE . 20.4 t0 65.55 41.69 4.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.1 26.07 71.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -128.64 122.88 31.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -100.43 93.89 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 1.4 pp -83.21 127.45 33.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.045 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.1 t -79.91 122.14 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -155.71 151.27 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.44 125.86 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.139 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' CD2' ' CZ2' ' A' ' 56' ' ' TRP . 8.3 m-85 -133.88 94.99 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.831 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 62' ' ' SER . . . -86.79 132.14 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.607 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.543 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.5 OUTLIER -51.45 88.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.68 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.64 161.47 29.66 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.262 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.487 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -103.21 -33.96 9.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.947 0.403 . . . . 0.0 110.995 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 85' ' ' VAL . 49.5 t -79.89 136.09 54.91 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.328 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.27 82.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.347 2.031 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 83' ' ' VAL . 23.1 t -84.05 139.5 17.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.32 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.733 HG22 ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -122.54 114.3 20.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.973 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -93.73 105.66 17.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 38.3 t -79.93 129.52 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' HD21 ' A' ' 74' ' ' LEU . 4.7 mt-30 -144.22 127.76 17.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.2 p -104.8 137.28 42.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.933 0.397 . . . . 0.0 111.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.74 ' HG2' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.83 156.53 25.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.312 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.789 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -92.34 134.58 34.78 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.898 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.48 144.36 51.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.902 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 p -102.58 143.69 31.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' H ' HG22 ' A' ' 47' ' ' THR . . . -49.83 122.05 6.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.371 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.08 -155.86 26.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.8 129.29 41.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -144.2 135.92 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -88.12 128.79 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CE1' ' N ' ' A' ' 70' ' ' ASP . 27.2 m-85 -128.42 147.39 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' HA2' ' CZ3' ' A' ' 40' ' ' TRP . . . 159.33 -155.4 26.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.194 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.715 ' CG1' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -144.07 122.89 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.713 -0.244 . . . . 0.0 110.447 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -127.6 173.22 10.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.154 0.502 . . . . 0.0 111.894 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.549 HG22 ' OD1' ' A' ' 65' ' ' ASN . 47.0 t -126.89 128.28 70.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.659 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.43 -170.96 14.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.792 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -59.51 -37.43 78.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -62.06 -28.99 69.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.8 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -158.1 88.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.441 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -90.05 145.65 24.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.895 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.25 170.52 18.25 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.814 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.79 149.24 22.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.9 tpt -164.41 130.04 2.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.662 0.268 . . . . 0.0 111.174 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 26.8 t30 -80.78 172.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 38' ' ' VAL . 11.0 t -153.85 119.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.1 OUTLIER -96.82 -58.94 1.91 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.99 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -179.41 144.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.738 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 8.1 mp -88.31 159.84 17.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 9.6 tppt? -136.29 140.57 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -150.0 107.94 3.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.15 178.29 5.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.193 0.52 . . . . 0.0 111.752 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.95 59.48 2.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.091 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.819 HD21 ' OE2' ' A' ' 49' ' ' GLU . 6.0 mp 43.09 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.519 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.451 ' CZ3' ' HG3' ' A' ' 45' ' ' PRO . 20.0 m-90 -158.46 106.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.476 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.429 HG23 ' CB ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -98.31 148.71 23.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.276 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CB ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -124.83 100.75 6.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.653 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -66.85 148.9 51.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.52 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . -63.15 -24.08 67.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.498 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.82 -24.71 63.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 94.1 p -107.31 29.53 7.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.765 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.798 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . . . -124.6 -165.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.75 104.21 12.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.796 ' CD1' HD23 ' A' ' 24' ' ' LEU . 15.6 mm -79.79 98.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.624 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 60.3 m -83.8 115.96 22.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.194 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.556 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -51.65 154.0 3.69 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 36' ' ' SER . 53.0 Cg_endo -66.82 1.94 2.58 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.11 -1.204 . . . . 0.0 113.472 0.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.4 141.66 54.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.592 ' HA ' HG21 ' A' ' 18' ' ' ILE . 9.5 tt0 -141.65 144.61 34.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.539 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.796 HD23 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.93 91.04 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.782 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 25' ' ' VAL . 5.2 m -90.38 109.34 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.742 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 61.63 55.51 28.31 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.684 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 3.7 m120 58.49 20.88 7.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.195 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 26' ' ' GLY . 3.6 t -134.61 144.55 34.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.232 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' VAL . . . -78.5 143.17 26.7 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.762 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.8 OUTLIER -144.15 110.76 5.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 111.639 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.785 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -88.52 170.36 10.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.578 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 2.0 tt0 -159.98 113.6 2.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.754 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.24 169.09 1.64 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.664 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.55 42.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.27 44.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.245 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -99.26 156.77 16.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.981 0.39 . . . . 0.0 110.736 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -170.21 144.24 2.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.34 89.47 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.027 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.701 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 28.4 mm -90.12 157.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 0.0 112.281 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.802 ' CZ3' HD23 ' A' ' 117' ' ' LEU . 1.4 m-90 -133.07 149.06 52.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.663 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -106.73 111.67 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.119 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.442 HG11 ' CE1' ' A' ' 11' ' ' TYR . 27.3 m -151.0 -179.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.508 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -153.58 111.95 3.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.718 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 95' ' ' ALA . 2.4 m -54.77 143.18 51.59 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.902 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 9' ' ' TRP . 58.7 Cg_endo -73.53 -52.65 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.49 2.126 . . . . 0.0 113.014 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 47' ' ' THR . 20.7 t -115.35 159.99 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.835 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 47' ' ' THR . 1.1 m -86.88 88.26 7.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.733 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.49 -137.11 2.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.603 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.758 ' OE1' HD11 ' A' ' 122' ' ' LEU . 3.9 tt0 -129.05 137.43 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.675 ' CD1' HD23 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -124.74 159.45 30.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.768 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 110.32 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 52' ' ' ILE . 1.1 mm -84.11 119.45 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.464 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -109.8 124.37 51.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.513 ' HG ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.44 124.91 45.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.17 0.51 . . . . 0.0 110.944 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 4.0 m -117.04 132.73 56.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.566 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.485 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -146.03 161.81 39.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.805 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.4 p -160.4 72.26 0.47 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.099 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -111.1 90.83 12.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.642 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.468 ' CA ' ' HB ' ' A' ' 82' ' ' THR . 51.3 Cg_exo -53.73 81.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.935 1.757 . . . . 0.0 112.594 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 58' ' ' SER . 7.1 t80 -176.12 -115.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.433 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.504 ' N ' ' HB2' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 179.11 146.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.354 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.518 ' OG ' ' HA ' ' A' ' 79' ' ' ALA . 11.6 p -140.73 -135.14 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 62' ' ' SER . 6.6 mtmt -165.56 174.2 10.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 21.6 t -38.12 140.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.605 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.567 ' OD1' HG22 ' A' ' 104' ' ' VAL . 1.6 t-20 -148.6 169.25 20.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.967 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.46 137.6 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.861 HD13 HG13 ' A' ' 102' ' ' VAL . 13.1 tp -118.85 109.98 16.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.016 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 22.7 t -85.65 99.08 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.567 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.795 ' HE3' HD11 ' A' ' 67' ' ' LEU . 37.1 mtt -131.26 106.75 8.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.126 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.613 ' CG ' HD12 ' A' ' 93' ' ' LEU . 43.5 t0 90.18 24.03 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.89 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.08 17.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.823 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 149.35 23.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -104.19 108.86 20.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.508 HD21 HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -87.86 144.4 26.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.131 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -82.25 131.5 35.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.408 ' O ' HG13 ' A' ' 64' ' ' VAL . 8.8 t80 -160.02 151.25 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.5 122.73 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.15 139.36 51.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.476 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' OG ' ' A' ' 62' ' ' SER . . . -124.45 168.4 13.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.355 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 14.3 mt-10 -95.99 88.18 4.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -94.98 142.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.895 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.468 ' HB ' ' CA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -81.21 -31.63 33.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.735 0.302 . . . . 0.0 111.42 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 85' ' ' VAL . 74.3 t -79.4 132.89 61.01 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.562 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.0 81.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.47 2.113 . . . . 0.0 111.857 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 83' ' ' VAL . 22.3 t -79.73 132.82 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.006 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 1.7 p -112.62 146.51 38.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 41.7 t80 -141.9 109.77 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.601 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.4 HG22 ' ND2' ' A' ' 53' ' ' ASN . 40.6 t -79.62 145.86 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.749 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.34 112.84 5.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.31 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -83.94 117.63 23.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.939 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HZ3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -144.41 156.2 44.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.8 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -94.83 125.87 39.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.085 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.951 178.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.86 147.54 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.07 0.462 . . . . 0.0 111.228 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 44' ' ' VAL . . . -52.67 134.56 35.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.236 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.86 -156.55 25.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.559 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 116.97 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -136.18 136.55 40.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 m -95.91 146.88 24.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.543 ' CE2' HD11 ' A' ' 119' ' ' LEU . 7.6 m-85 -139.39 159.07 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 111.213 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CZ3' ' A' ' 40' ' ' TRP . . . 154.92 -154.41 25.5 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.079 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.861 HG13 HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -136.42 118.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 110.488 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -100.73 160.75 14.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.43 0.633 . . . . 0.0 112.361 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.785 ' CG2' HD13 ' A' ' 31' ' ' LEU . 41.5 t -130.21 108.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.53 -176.95 19.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.8 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -67.55 -41.47 84.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.11 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.795 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -143.83 96.82 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -118.39 137.93 52.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 95.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.589 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -37.94 132.28 0.98 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.311 0.244 . . . . 0.0 111.361 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 8.2 ptm -157.11 157.26 34.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.515 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -80.64 155.98 26.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.514 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 38' ' ' VAL . 48.2 t -139.55 96.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.526 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 2.2 t60 -69.22 -56.3 8.0 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 p -177.96 159.92 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.716 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.802 HD23 ' CZ3' ' A' ' 40' ' ' TRP . 1.6 mm? -106.9 97.79 7.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CB ' HG23 ' A' ' 10' ' ' THR . 7.7 tttm -85.21 130.23 34.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.268 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.595 HD23 ' CB ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -130.03 107.74 9.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.051 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 1.5 tt0 -105.97 167.2 9.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 111.615 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.632 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -81.09 54.44 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.644 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.758 HD11 ' OE1' ' A' ' 49' ' ' GLU . 1.7 mt 57.65 178.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.898 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.791 HG23 ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.956 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.753 HD13 HG12 ' A' ' 38' ' ' VAL . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.669 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' GLY . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ASN . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' O ' HG21 ' A' ' 104' ' ' VAL . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.956 ' CE2' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.73 HG11 ' CE2' ' A' ' 11' ' ' TYR . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' O ' HD12 ' A' ' 122' ' ' LEU . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 44' ' ' VAL . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' CD ' ' A' ' 91' ' ' LYS . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.753 ' HG ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.817 HD13 HG13 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 103' ' ' ARG . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.852 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.592 ' CG ' HD12 ' A' ' 93' ' ' LEU . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 85' ' ' VAL . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 83' ' ' VAL . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 83' ' ' VAL . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.842 ' C ' HD13 ' A' ' 93' ' ' LEU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.407 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.407 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 10.4 m-70 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 117' ' ' LEU . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.532 ' HA2' HD13 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.817 HG13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG2' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.766 HG13 ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.688 ' HB3' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.766 ' HA ' HG13 ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.635 ' SD ' HG23 ' A' ' 114' ' ' VAL . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.629 ' HB3' HG12 ' A' ' 28' ' ' VAL . 36.7 m-20 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 38' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.541 ' N ' HG13 ' A' ' 28' ' ' VAL . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.852 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.791 ' HG2' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER 54.47 74.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.563 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.791 HG23 ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.956 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.753 HD13 HG12 ' A' ' 38' ' ' VAL . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.669 ' HA ' HD11 ' A' ' 24' ' ' LEU . 8.5 p30 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' GLY . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ASN . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' O ' HG21 ' A' ' 104' ' ' VAL . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.956 ' CE2' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.73 HG11 ' CE2' ' A' ' 11' ' ' TYR . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' O ' HD12 ' A' ' 122' ' ' LEU . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 44' ' ' VAL . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' CD ' ' A' ' 91' ' ' LYS . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.753 ' HG ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.506 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.701 HD21 HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.817 HD13 HG13 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 103' ' ' ARG . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.852 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.592 ' CG ' HD12 ' A' ' 93' ' ' LEU . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 85' ' ' VAL . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 83' ' ' VAL . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 83' ' ' VAL . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.842 ' C ' HD13 ' A' ' 93' ' ' LEU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 117' ' ' LEU . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.532 ' HA2' HD13 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.817 HG13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG2' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.766 HG13 ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.688 ' HB3' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.766 ' HA ' HG13 ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.635 ' SD ' HG23 ' A' ' 114' ' ' VAL . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.629 ' HB3' HG12 ' A' ' 28' ' ' VAL . 3.0 m120 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 38' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.541 ' N ' HG13 ' A' ' 28' ' ' VAL . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.852 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.791 ' HG2' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.446 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 11.2 m-90 -104.46 104.75 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -98.63 98.59 9.72 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 178.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.552 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -80.67 94.95 6.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.958 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 155.43 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.806 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' CB ' HD21 ' A' ' 24' ' ' LEU . . . -72.09 -19.49 61.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.548 ' HB2' ' CG ' ' A' ' 27' ' ' ASN . . . -69.91 -13.5 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.82 -24.13 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.976 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.877 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . . . -79.92 -176.38 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.5 p -107.79 114.36 28.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.734 HD12 HG12 ' A' ' 38' ' ' VAL . 4.3 mm -85.54 114.13 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -96.46 116.21 28.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.33 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.564 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -46.96 151.45 1.13 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.028 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 36' ' ' SER . 55.5 Cg_endo -67.02 3.33 2.38 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.044 -1.232 . . . . 0.0 113.409 0.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.59 139.79 56.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.019 0.437 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.1 147.1 45.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.709 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -91.27 101.05 13.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.773 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 25' ' ' VAL . 24.7 m -100.54 98.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.857 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.672 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 60.55 60.48 8.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.262 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.709 ' HA ' HD11 ' A' ' 24' ' ' LEU . 1.0 OUTLIER 58.01 21.65 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.831 0.348 . . . . 0.0 110.903 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 26' ' ' GLY . 34.8 t -127.91 118.64 49.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' HG11 ' A' ' 38' ' ' VAL . . . -67.15 149.89 51.45 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.172 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.7 mm-40 -140.06 158.67 43.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.538 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -145.17 153.21 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.309 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 11.1 mt-30 -151.32 92.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 111.094 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.05 -173.52 34.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.388 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.36 146.9 34.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.16 -24.74 25.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.003 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -82.06 151.24 27.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.861 0.33 . . . . 0.0 110.433 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . . . -170.04 133.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -108.67 89.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.984 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.824 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 50.4 mm -92.89 153.36 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.209 0.528 . . . . 0.0 112.146 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.877 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 1.4 m-90 -125.47 148.65 48.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.752 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.1 m-80 -119.5 111.71 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.613 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 41' ' ' ASN . 17.1 m -157.66 -179.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.194 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -124.99 137.74 54.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' ND1' ' A' ' 98' ' ' HIS . 87.4 t -59.96 138.63 90.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 44' ' ' VAL . 33.7 Cg_endo -65.32 -56.12 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.525 2.15 . . . . 0.0 112.583 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.45 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 0.0 111.802 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.657 HG23 ' HB2' ' A' ' 95' ' ' ALA . 20.6 p -107.85 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.23 -157.49 9.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HG2' HD12 ' A' ' 122' ' ' LEU . 35.1 tt0 -110.33 123.2 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.96 ' CD2' HD13 ' A' ' 93' ' ' LEU . 3.7 m-85 -123.45 146.88 47.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.554 ' HB3' HD21 ' A' ' 122' ' ' LEU . 6.5 ptt180 -88.71 119.04 28.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 91' ' ' LYS . 5.3 mt -78.95 146.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 2.2 m-20 -138.77 112.8 8.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.406 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.569 ' CD2' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.41 118.72 36.65 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.134 0.492 . . . . 0.0 110.328 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.5 m -105.13 129.23 53.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.145 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.758 ' CE3' ' HB2' ' A' ' 81' ' ' ALA . 1.6 p-90 -160.03 148.72 17.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.24 109.32 1.52 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 10.0 m -154.0 84.68 4.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 52.6 Cg_exo -56.13 85.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.574 2.182 . . . . 0.0 112.078 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -117.38 -92.89 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.665 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -139.41 -106.52 0.17 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 12.8 t -175.8 144.23 0.62 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.898 0.38 . . . . 0.0 111.582 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 169.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.855 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 77' ' ' ALA . 17.2 t -83.76 160.33 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.845 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 64' ' ' VAL . 42.9 m-80 -159.56 166.46 30.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.741 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -108.31 136.96 47.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.764 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.04 HD23 HD11 ' A' ' 74' ' ' LEU . 12.5 tp -118.12 103.87 10.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 11.1 t -85.95 110.04 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.721 ' SD ' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -126.3 101.21 6.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.489 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' HB2' ' CE ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER 78.58 32.81 0.3 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.869 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.0 16.89 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.937 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 128.42 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -98.0 99.03 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.22 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.04 HD11 HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -80.34 131.32 35.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.74 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.5 t -79.81 105.97 11.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.012 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 3.5 t80 -127.34 120.04 27.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.472 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -105.52 141.99 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.545 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.551 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -169.94 -93.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.149 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' HZ3' ' A' ' 56' ' ' TRP . . . -169.15 -153.92 0.12 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.417 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.511 ' HG2' ' CB ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -104.96 32.39 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.253 0.549 . . . . 0.0 109.711 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.758 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . . . 47.46 -168.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.949 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.971 HG23 HG13 ' A' ' 83' ' ' VAL . 2.4 t -160.4 -41.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.028 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.971 HG13 HG23 ' A' ' 82' ' ' THR . 0.9 OUTLIER -118.36 -175.85 0.35 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.857 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' N ' HG23 ' A' ' 83' ' ' VAL . 14.5 Cg_exo -67.22 63.0 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.523 1.482 . . . . 0.0 109.813 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.514 ' CG2' HG22 ' A' ' 83' ' ' VAL . 26.0 t -79.34 113.51 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.064 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 60.4 p -97.69 156.14 16.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.507 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.47 ' CG ' ' OE1' ' A' ' 89' ' ' GLN . 5.7 t80 -129.18 129.07 44.6 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.51 134.69 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 112.123 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.47 ' OE1' ' CG ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -144.25 112.29 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.747 178.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.609 HG22 HD11 ' A' ' 122' ' ' LEU . 6.3 p -80.27 117.51 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.627 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.1 ttpt -155.58 145.51 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.501 HG22 ' CA ' ' A' ' 49' ' ' GLU . 3.9 p -94.95 146.06 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.474 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.96 HD13 ' CD2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -124.87 143.96 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.45 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -95.44 163.14 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.612 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.657 ' HB2' HG23 ' A' ' 47' ' ' THR . . . -76.78 122.03 24.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.76 -148.05 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.07 144.54 26.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.554 ' ND1' HG23 ' A' ' 44' ' ' VAL . 73.4 m80 -154.53 147.03 24.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 p -96.74 144.72 26.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.689 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.763 ' HB3' HD22 ' A' ' 117' ' ' LEU . 44.3 m-85 -142.24 170.16 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.255 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.09 170.49 11.92 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.62 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.661 ' H ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -119.19 112.77 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.543 ' HB2' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -116.22 -179.43 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.375 0.607 . . . . 0.0 112.425 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 108' ' ' ASP . 16.9 t -146.36 122.78 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.1 -170.32 12.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -32.34 69.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.935 0.398 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -65.64 -28.15 68.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.735 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.628 ' O ' HG13 ' A' ' 104' ' ' VAL . 19.5 m-20 -153.82 67.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.476 ' HA ' HG12 ' A' ' 104' ' ' VAL . 1.1 p90 -68.51 154.16 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' HG11 ' A' ' 104' ' ' VAL . . . 143.34 -170.62 25.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.46 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -123.36 150.86 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.056 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -163.86 145.42 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 8.8 t-20 -80.93 170.47 16.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.603 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 38' ' ' VAL . 57.1 t -154.4 106.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.083 0.468 . . . . 0.0 110.773 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 37.7 t-80 -87.44 -55.45 3.79 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.565 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.658 ' OG ' HG22 ' A' ' 10' ' ' THR . 3.4 t -177.0 137.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -87.06 111.56 21.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.808 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.703 ' HB3' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -120.16 130.3 54.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.501 . . . . 0.0 112.291 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.917 HD22 HD21 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.69 107.78 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.301 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -99.53 151.58 20.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.019 0.437 . . . . 0.0 111.877 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.517 HD13 ' CE1' ' A' ' 50' ' ' TYR . 1.1 mm? -65.3 138.87 58.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.736 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.628 HD12 ' HG2' ' A' ' 49' ' ' GLU . 7.3 mt . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.743 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -123.59 135.88 54.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.442 . . . . 0.0 111.673 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 160.27 15.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.252 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.635 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -137.78 94.72 2.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.962 0.411 . . . . 0.0 110.746 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 p -70.45 142.59 51.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.387 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 114' ' ' VAL . . . -68.77 -19.77 64.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.597 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' A' ' 27' ' ' ASN . . . -69.87 -30.82 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -104.86 29.92 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . . . -123.68 -165.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.7 m -114.02 104.09 11.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.928 HD12 HG12 ' A' ' 38' ' ' VAL . 1.5 mm -85.43 95.24 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 70.4 m -79.95 120.59 24.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.589 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -52.04 155.29 3.32 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.856 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 36' ' ' SER . 56.0 Cg_endo -67.99 4.86 2.49 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.985 -1.256 . . . . 0.0 113.316 0.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.57 142.01 53.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 110.52 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -137.64 145.05 42.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -91.68 95.5 9.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 25' ' ' VAL . 11.5 m -94.61 98.76 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.053 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 60.49 59.96 9.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.577 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.751 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.6 OUTLIER 59.72 20.72 9.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.717 0.294 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 26' ' ' GLY . 1.6 t -131.91 122.96 50.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD1' ' A' ' 113' ' ' ASN . . . -67.22 147.83 49.49 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.203 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 25' ' ' VAL . 5.2 mt-10 -144.48 105.0 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 111.259 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 112' ' ' MET . 0.3 OUTLIER -88.65 159.67 17.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.125 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -154.81 87.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.821 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.2 175.1 45.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.364 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.01 151.05 43.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.08 -27.99 15.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.813 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.57 151.59 37.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.508 0.194 . . . . 0.0 110.483 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . . . -170.15 107.13 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -89.25 89.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 40' ' ' TRP . 17.6 mm -95.39 157.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 112.523 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.839 ' NE1' ' HB2' ' A' ' 16' ' ' ALA . 4.6 m-90 -130.86 146.5 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.365 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.18 111.9 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.635 HG11 ' CE2' ' A' ' 11' ' ' TYR . 17.2 m -149.82 -176.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.65 135.7 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.399 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.612 HG13 ' HE2' ' A' ' 50' ' ' TYR . 40.3 t -69.24 130.1 91.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.569 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HG3' ' CH2' ' A' ' 9' ' ' TRP . 71.9 Cg_endo -76.92 -45.01 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.343 2.029 . . . . 0.0 113.033 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.507 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -122.28 163.67 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 111.881 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 95' ' ' ALA . 41.1 p -94.79 72.28 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.26 -132.62 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.802 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.819 ' OE2' HD21 ' A' ' 122' ' ' LEU . 37.0 tt0 -132.16 149.42 52.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.954 0.407 . . . . 0.0 111.227 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.832 ' CD2' HD23 ' A' ' 93' ' ' LEU . 20.5 m-85 -137.57 160.83 38.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.232 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.573 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.25 128.27 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.746 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.679 HD12 ' CE ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -99.13 149.05 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' A' ' 86' ' ' THR . 0.1 OUTLIER -148.42 119.44 7.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.551 ' CD2' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.58 123.86 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 133.78 51.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.266 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.547 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -157.9 154.54 28.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.342 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -161.82 81.19 0.57 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -116.44 90.68 31.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.487 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 31.3 Cg_exo -61.59 61.58 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.215 1.944 . . . . 0.0 113.504 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -166.81 -88.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.5 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -45.19 174.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 45.5 m -173.94 105.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.778 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -171.16 161.45 6.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.871 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 65' ' ' ASN . 12.0 t -56.53 163.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.699 ' ND2' HG22 ' A' ' 104' ' ' VAL . 24.3 t-20 -160.86 161.5 31.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.039 0.447 . . . . 0.0 111.433 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.573 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -103.12 137.19 41.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' CG1' ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.49 107.61 18.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -91.06 96.85 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.953 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.551 ' HE1' ' CD2' ' A' ' 54' ' ' LEU . 4.4 mmt -132.95 114.4 13.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.432 ' N ' ' CE1' ' A' ' 100' ' ' PHE . 20.4 t0 65.55 41.69 4.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.1 26.07 71.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -128.64 122.88 31.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -100.43 93.89 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 1.4 pp -83.21 127.45 33.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.045 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.1 t -79.91 122.14 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -155.71 151.27 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.44 125.86 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.139 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' CD2' ' CZ2' ' A' ' 56' ' ' TRP . 8.3 m-85 -133.88 94.99 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.831 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 62' ' ' SER . . . -86.79 132.14 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.607 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.543 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.5 OUTLIER -51.45 88.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.68 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.64 161.47 29.66 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.262 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.487 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -103.21 -33.96 9.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.947 0.403 . . . . 0.0 110.995 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 85' ' ' VAL . 49.5 t -79.89 136.09 54.91 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.328 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.27 82.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.347 2.031 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 83' ' ' VAL . 23.1 t -84.05 139.5 17.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.32 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.733 HG22 ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -122.54 114.3 20.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.973 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -93.73 105.66 17.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 38.3 t -79.93 129.52 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' HD21 ' A' ' 74' ' ' LEU . 4.7 mt-30 -144.22 127.76 17.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.2 p -104.8 137.28 42.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.933 0.397 . . . . 0.0 111.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.74 ' HG2' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.83 156.53 25.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.312 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.789 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -92.34 134.58 34.78 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.898 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.48 144.36 51.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.902 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 p -102.58 143.69 31.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' H ' HG22 ' A' ' 47' ' ' THR . . . -49.83 122.05 6.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.371 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.08 -155.86 26.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.8 129.29 41.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -144.2 135.92 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -88.12 128.79 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CE1' ' N ' ' A' ' 70' ' ' ASP . 27.2 m-85 -128.42 147.39 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' HA2' ' CZ3' ' A' ' 40' ' ' TRP . . . 159.33 -155.4 26.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.194 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.715 ' CG1' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -144.07 122.89 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.713 -0.244 . . . . 0.0 110.447 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -127.6 173.22 10.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.154 0.502 . . . . 0.0 111.894 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.699 HG22 ' ND2' ' A' ' 65' ' ' ASN . 47.0 t -126.89 128.28 70.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.659 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.43 -170.96 14.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.792 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -59.51 -37.43 78.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -62.06 -28.99 69.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.8 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -158.1 88.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.441 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -90.05 145.65 24.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.895 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.25 170.52 18.25 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.814 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.79 149.24 22.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.9 tpt -164.41 130.04 2.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.662 0.268 . . . . 0.0 111.174 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 26.8 t30 -80.78 172.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 38' ' ' VAL . 11.0 t -153.85 119.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.1 OUTLIER -96.82 -58.94 1.91 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.99 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -179.41 144.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.738 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 8.1 mp -88.31 159.84 17.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 9.6 tppt? -136.29 140.57 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -150.0 107.94 3.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.15 178.29 5.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.193 0.52 . . . . 0.0 111.752 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.95 59.48 2.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.091 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.819 HD21 ' OE2' ' A' ' 49' ' ' GLU . 6.0 mp . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.519 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.451 ' CZ3' ' HG3' ' A' ' 45' ' ' PRO . 20.0 m-90 -158.46 106.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.476 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.429 HG23 ' CB ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -98.31 148.71 23.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.276 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CB ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -124.83 100.75 6.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.653 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -66.85 148.9 51.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.52 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . -63.15 -24.08 67.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.498 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.82 -24.71 63.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 94.1 p -107.31 29.53 7.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.765 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.798 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . . . -124.6 -165.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.75 104.21 12.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.796 ' CD1' HD23 ' A' ' 24' ' ' LEU . 15.6 mm -79.79 98.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.624 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 60.3 m -83.8 115.96 22.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.194 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.556 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -51.65 154.0 3.69 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 36' ' ' SER . 53.0 Cg_endo -66.82 1.94 2.58 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.11 -1.204 . . . . 0.0 113.472 0.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.4 141.66 54.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.592 ' HA ' HG21 ' A' ' 18' ' ' ILE . 9.5 tt0 -141.65 144.61 34.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.539 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.796 HD23 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.93 91.04 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.782 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 25' ' ' VAL . 5.2 m -90.38 109.34 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.742 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 61.63 55.51 28.31 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.684 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 3.7 m120 58.49 20.88 7.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.195 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 26' ' ' GLY . 3.6 t -134.61 144.55 34.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.232 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' VAL . . . -78.5 143.17 26.7 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.762 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.8 OUTLIER -144.15 110.76 5.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 111.639 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.785 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -88.52 170.36 10.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.578 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 2.0 tt0 -159.98 113.6 2.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.754 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.24 169.09 1.64 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.664 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.55 42.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.27 44.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.245 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -99.26 156.77 16.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.981 0.39 . . . . 0.0 110.736 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -170.21 144.24 2.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.34 89.47 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.027 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.701 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 28.4 mm -90.12 157.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 0.0 112.281 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.802 ' CZ3' HD23 ' A' ' 117' ' ' LEU . 1.4 m-90 -133.07 149.06 52.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.663 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -106.73 111.67 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.119 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.442 HG11 ' CE1' ' A' ' 11' ' ' TYR . 27.3 m -151.0 -179.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.508 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -153.58 111.95 3.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.718 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 95' ' ' ALA . 2.4 m -54.77 143.18 51.59 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.902 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 9' ' ' TRP . 58.7 Cg_endo -73.53 -52.65 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.49 2.126 . . . . 0.0 113.014 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 47' ' ' THR . 20.7 t -115.35 159.99 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.835 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 47' ' ' THR . 1.1 m -86.88 88.26 7.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.733 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.49 -137.11 2.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.603 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.758 ' OE1' HD11 ' A' ' 122' ' ' LEU . 3.9 tt0 -129.05 137.43 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.675 ' CD1' HD23 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -124.74 159.45 30.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.768 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 110.32 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 52' ' ' ILE . 1.1 mm -84.11 119.45 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.464 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -109.8 124.37 51.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.513 ' HG ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.44 124.91 45.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.17 0.51 . . . . 0.0 110.944 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 4.0 m -117.04 132.73 56.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.566 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.485 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -146.03 161.81 39.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.805 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.4 p -160.4 72.26 0.47 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.099 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -111.1 90.83 12.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.642 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.468 ' CA ' ' HB ' ' A' ' 82' ' ' THR . 51.3 Cg_exo -53.73 81.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.935 1.757 . . . . 0.0 112.594 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 58' ' ' SER . 7.1 t80 -176.12 -115.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.433 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.504 ' N ' ' HB2' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 179.11 146.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.354 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.518 ' OG ' ' HA ' ' A' ' 79' ' ' ALA . 11.6 p -140.73 -135.14 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 62' ' ' SER . 6.6 mtmt -165.56 174.2 10.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 21.6 t -38.12 140.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.605 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.567 ' OD1' HG22 ' A' ' 104' ' ' VAL . 1.6 t-20 -148.6 169.25 20.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.967 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.46 137.6 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.861 HD13 HG13 ' A' ' 102' ' ' VAL . 13.1 tp -118.85 109.98 16.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.016 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 22.7 t -85.65 99.08 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.567 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.795 ' HE3' HD11 ' A' ' 67' ' ' LEU . 37.1 mtt -131.26 106.75 8.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.126 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.613 ' CG ' HD12 ' A' ' 93' ' ' LEU . 43.5 t0 90.18 24.03 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.89 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.08 17.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.823 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 149.35 23.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -104.19 108.86 20.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.508 HD21 HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -87.86 144.4 26.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.131 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -82.25 131.5 35.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.408 ' O ' HG13 ' A' ' 64' ' ' VAL . 8.8 t80 -160.02 151.25 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.5 122.73 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.15 139.36 51.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.476 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' OG ' ' A' ' 62' ' ' SER . . . -124.45 168.4 13.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.355 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 14.3 mt-10 -95.99 88.18 4.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -94.98 142.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.895 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.468 ' HB ' ' CA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -81.21 -31.63 33.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.735 0.302 . . . . 0.0 111.42 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 85' ' ' VAL . 74.3 t -79.4 132.89 61.01 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.562 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.0 81.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.47 2.113 . . . . 0.0 111.857 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 83' ' ' VAL . 22.3 t -79.73 132.82 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.006 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 1.7 p -112.62 146.51 38.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 41.7 t80 -141.9 109.77 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.601 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.4 HG22 ' ND2' ' A' ' 53' ' ' ASN . 40.6 t -79.62 145.86 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.749 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.34 112.84 5.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.31 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -83.94 117.63 23.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.939 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HZ3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -144.41 156.2 44.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.8 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -94.83 125.87 39.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.085 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.951 178.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.86 147.54 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.07 0.462 . . . . 0.0 111.228 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 44' ' ' VAL . . . -52.67 134.56 35.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.236 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.86 -156.55 25.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.559 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 116.97 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -136.18 136.55 40.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 m -95.91 146.88 24.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.543 ' CE2' HD11 ' A' ' 119' ' ' LEU . 7.6 m-85 -139.39 159.07 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 111.213 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CZ3' ' A' ' 40' ' ' TRP . . . 154.92 -154.41 25.5 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.079 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.861 HG13 HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -136.42 118.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 110.488 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -100.73 160.75 14.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.43 0.633 . . . . 0.0 112.361 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.785 ' CG2' HD13 ' A' ' 31' ' ' LEU . 41.5 t -130.21 108.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.53 -176.95 19.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.8 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -67.55 -41.47 84.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.11 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.795 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -143.83 96.82 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -118.39 137.93 52.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 95.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.589 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -37.94 132.28 0.98 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.311 0.244 . . . . 0.0 111.361 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 8.2 ptm -157.11 157.26 34.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.515 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -80.64 155.98 26.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.514 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 38' ' ' VAL . 48.2 t -139.55 96.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.526 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 2.2 t60 -69.22 -56.3 8.0 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 p -177.96 159.92 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.716 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.802 HD23 ' CZ3' ' A' ' 40' ' ' TRP . 1.6 mm? -106.9 97.79 7.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CB ' HG23 ' A' ' 10' ' ' THR . 7.7 tttm -85.21 130.23 34.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.268 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.595 HD23 ' CB ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -130.03 107.74 9.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.051 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 1.5 tt0 -105.97 167.2 9.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 111.615 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.632 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -81.09 54.44 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.644 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.758 HD11 ' OE1' ' A' ' 49' ' ' GLU . 1.7 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.898 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.791 HG23 ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.956 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.753 HD13 HG12 ' A' ' 38' ' ' VAL . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.669 ' HA ' HD11 ' A' ' 24' ' ' LEU . 8.5 p30 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' GLY . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ASN . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' O ' HG21 ' A' ' 104' ' ' VAL . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.956 ' CE2' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.73 HG11 ' CE2' ' A' ' 11' ' ' TYR . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' O ' HD12 ' A' ' 122' ' ' LEU . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 44' ' ' VAL . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' CD ' ' A' ' 91' ' ' LYS . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.753 ' HG ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.506 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.701 HD21 HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.817 HD13 HG13 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 103' ' ' ARG . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.852 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.592 ' CG ' HD12 ' A' ' 93' ' ' LEU . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 85' ' ' VAL . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 83' ' ' VAL . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 83' ' ' VAL . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.842 ' C ' HD13 ' A' ' 93' ' ' LEU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 117' ' ' LEU . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.532 ' HA2' HD13 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.817 HG13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG2' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.766 HG13 ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.688 ' HB3' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.766 ' HA ' HG13 ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.635 ' SD ' HG23 ' A' ' 114' ' ' VAL . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.629 ' HB3' HG12 ' A' ' 28' ' ' VAL . 3.0 m120 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 38' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.541 ' N ' HG13 ' A' ' 28' ' ' VAL . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.852 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.791 ' HG2' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.791 HG23 ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.956 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.753 HD13 HG12 ' A' ' 38' ' ' VAL . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.669 ' HA ' HD11 ' A' ' 24' ' ' LEU . 8.5 p30 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' GLY . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ASN . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' O ' HG21 ' A' ' 104' ' ' VAL . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.956 ' CE2' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.73 HG11 ' CE2' ' A' ' 11' ' ' TYR . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' O ' HD12 ' A' ' 122' ' ' LEU . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 44' ' ' VAL . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' CD ' ' A' ' 91' ' ' LYS . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.753 ' HG ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.701 HD21 HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.817 HD13 HG13 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 103' ' ' ARG . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.852 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.592 ' CG ' HD12 ' A' ' 93' ' ' LEU . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 85' ' ' VAL . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 83' ' ' VAL . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 83' ' ' VAL . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.842 ' C ' HD13 ' A' ' 93' ' ' LEU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 117' ' ' LEU . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.532 ' HA2' HD13 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.817 HG13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG2' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.766 HG13 ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.688 ' HB3' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.766 ' HA ' HG13 ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.635 ' SD ' HG23 ' A' ' 114' ' ' VAL . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.629 ' HB3' HG12 ' A' ' 28' ' ' VAL . 3.0 m120 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 38' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.541 ' N ' HG13 ' A' ' 28' ' ' VAL . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.852 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.791 ' HG2' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER 54.47 74.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.563 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.446 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 11.2 m-90 -104.46 104.75 14.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.469 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -98.63 98.59 9.72 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 178.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.552 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -80.67 94.95 6.45 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.958 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 155.43 1.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.806 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' CB ' HD21 ' A' ' 24' ' ' LEU . . . -72.09 -19.49 61.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.548 ' HB2' ' CG ' ' A' ' 27' ' ' ASN . . . -69.91 -13.5 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.82 -24.13 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.976 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.877 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . . . -79.92 -176.38 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.138 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.5 p -107.79 114.36 28.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.734 HD12 HG12 ' A' ' 38' ' ' VAL . 4.3 mm -85.54 114.13 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.882 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -96.46 116.21 28.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.33 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.564 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -46.96 151.45 1.13 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.028 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 36' ' ' SER . 55.5 Cg_endo -67.02 3.33 2.38 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.044 -1.232 . . . . 0.0 113.409 0.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.59 139.79 56.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.019 0.437 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.1 147.1 45.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.709 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -91.27 101.05 13.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.773 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 25' ' ' VAL . 24.7 m -100.54 98.95 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.857 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.672 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 60.55 60.48 8.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.262 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.709 ' HA ' HD11 ' A' ' 24' ' ' LEU . 1.0 OUTLIER 58.01 21.65 8.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.831 0.348 . . . . 0.0 110.903 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 26' ' ' GLY . 34.8 t -127.91 118.64 49.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' HG11 ' A' ' 38' ' ' VAL . . . -67.15 149.89 51.45 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.172 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.7 mm-40 -140.06 158.67 43.69 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.538 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -145.17 153.21 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.309 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 11.1 mt-30 -151.32 92.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 111.094 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.05 -173.52 34.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.388 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.36 146.9 34.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.16 -24.74 25.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.003 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -82.06 151.24 27.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.861 0.33 . . . . 0.0 110.433 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . . . -170.04 133.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -108.67 89.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.984 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.824 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 50.4 mm -92.89 153.36 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.209 0.528 . . . . 0.0 112.146 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.877 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 1.4 m-90 -125.47 148.65 48.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.752 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.1 m-80 -119.5 111.71 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.613 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 41' ' ' ASN . 17.1 m -157.66 -179.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.194 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -124.99 137.74 54.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' ND1' ' A' ' 98' ' ' HIS . 87.4 t -59.96 138.63 90.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 44' ' ' VAL . 33.7 Cg_endo -65.32 -56.12 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.525 2.15 . . . . 0.0 112.583 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.45 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 0.0 111.802 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.657 HG23 ' HB2' ' A' ' 95' ' ' ALA . 20.6 p -107.85 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.23 -157.49 9.51 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HG2' HD12 ' A' ' 122' ' ' LEU . 35.1 tt0 -110.33 123.2 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.96 ' CD2' HD13 ' A' ' 93' ' ' LEU . 3.7 m-85 -123.45 146.88 47.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.554 ' HB3' HD21 ' A' ' 122' ' ' LEU . 6.5 ptt180 -88.71 119.04 28.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 91' ' ' LYS . 5.3 mt -78.95 146.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 2.2 m-20 -138.77 112.8 8.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.406 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.569 ' CD2' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.41 118.72 36.65 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.134 0.492 . . . . 0.0 110.328 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.5 m -105.13 129.23 53.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.145 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.758 ' CE3' ' HB2' ' A' ' 81' ' ' ALA . 1.6 p-90 -160.03 148.72 17.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.24 109.32 1.52 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 0.0 111.379 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 113' ' ' ASN . 10.0 m -154.0 84.68 4.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HG3' ' OG1' ' A' ' 82' ' ' THR . 52.6 Cg_exo -56.13 85.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.574 2.182 . . . . 0.0 112.078 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -117.38 -92.89 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.665 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -139.41 -106.52 0.17 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 12.8 t -175.8 144.23 0.62 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.898 0.38 . . . . 0.0 111.582 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 169.5 1.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.855 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.773 HG13 ' HB2' ' A' ' 77' ' ' ALA . 17.2 t -83.76 160.33 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.845 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 64' ' ' VAL . 42.9 m-80 -159.56 166.46 30.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.741 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -108.31 136.96 47.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.764 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.04 HD23 HD11 ' A' ' 74' ' ' LEU . 12.5 tp -118.12 103.87 10.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 11.1 t -85.95 110.04 19.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.721 ' SD ' HD21 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -126.3 101.21 6.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.489 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' HB2' ' CE ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER 78.58 32.81 0.3 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.869 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.0 16.89 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.937 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 128.42 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -98.0 99.03 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.22 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.04 HD11 HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -80.34 131.32 35.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.74 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.5 t -79.81 105.97 11.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.012 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CE1' ' CD2' ' A' ' 78' ' ' PHE . 3.5 t80 -127.34 120.04 27.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.472 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -105.52 141.99 36.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.545 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.551 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -169.94 -93.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.149 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' HZ3' ' A' ' 56' ' ' TRP . . . -169.15 -153.92 0.12 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.417 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.511 ' HG2' ' CB ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -104.96 32.39 4.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.253 0.549 . . . . 0.0 109.711 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.758 ' HB2' ' CE3' ' A' ' 56' ' ' TRP . . . 47.46 -168.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.949 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.971 HG23 HG13 ' A' ' 83' ' ' VAL . 2.4 t -160.4 -41.66 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.028 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.971 HG13 HG23 ' A' ' 82' ' ' THR . 0.9 OUTLIER -118.36 -175.85 0.35 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.857 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' N ' HG23 ' A' ' 83' ' ' VAL . 14.5 Cg_exo -67.22 63.0 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.523 1.482 . . . . 0.0 109.813 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.514 ' CG2' HG22 ' A' ' 83' ' ' VAL . 26.0 t -79.34 113.51 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.064 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 60.4 p -97.69 156.14 16.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.507 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.47 ' CG ' ' OE1' ' A' ' 89' ' ' GLN . 5.7 t80 -129.18 129.07 44.6 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.51 134.69 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 112.123 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.47 ' OE1' ' CG ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -144.25 112.29 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.747 178.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.609 HG22 HD11 ' A' ' 122' ' ' LEU . 6.3 p -80.27 117.51 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.627 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.1 ttpt -155.58 145.51 21.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.217 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.501 HG22 ' CA ' ' A' ' 49' ' ' GLU . 3.9 p -94.95 146.06 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.474 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.96 HD13 ' CD2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -124.87 143.96 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.45 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -95.44 163.14 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.612 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.657 ' HB2' HG23 ' A' ' 47' ' ' THR . . . -76.78 122.03 24.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.76 -148.05 19.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.07 144.54 26.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.554 ' ND1' HG23 ' A' ' 44' ' ' VAL . 73.4 m80 -154.53 147.03 24.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 p -96.74 144.72 26.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.689 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.763 ' HB3' HD22 ' A' ' 117' ' ' LEU . 44.3 m-85 -142.24 170.16 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.255 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.09 170.49 11.92 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.62 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.661 ' H ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -119.19 112.77 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.543 ' HB2' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -116.22 -179.43 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.375 0.607 . . . . 0.0 112.425 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 108' ' ' ASP . 16.9 t -146.36 122.78 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.1 -170.32 12.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -32.34 69.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.935 0.398 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 m -65.64 -28.15 68.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.735 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.628 ' O ' HG13 ' A' ' 104' ' ' VAL . 19.5 m-20 -153.82 67.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.476 ' HA ' HG12 ' A' ' 104' ' ' VAL . 1.1 p90 -68.51 154.16 42.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' HG11 ' A' ' 104' ' ' VAL . . . 143.34 -170.62 25.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.46 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -123.36 150.86 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 111.056 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -163.86 145.42 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 8.8 t-20 -80.93 170.47 16.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.603 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 38' ' ' VAL . 57.1 t -154.4 106.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.083 0.468 . . . . 0.0 110.773 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 37.7 t-80 -87.44 -55.45 3.79 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.565 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.658 ' OG ' HG22 ' A' ' 10' ' ' THR . 3.4 t -177.0 137.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -87.06 111.56 21.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.808 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.703 ' HB3' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -120.16 130.3 54.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.501 . . . . 0.0 112.291 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.917 HD22 HD21 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.69 107.78 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.301 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -99.53 151.58 20.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.019 0.437 . . . . 0.0 111.877 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.517 HD13 ' CE1' ' A' ' 50' ' ' TYR . 1.1 mm? -65.3 138.87 58.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.736 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.628 HD12 ' HG2' ' A' ' 49' ' ' GLU . 7.3 mt -95.35 28.21 3.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.773 0.32 . . . . 0.0 110.743 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 -179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.719 0.295 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CH2' ' HG3' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -123.59 135.88 54.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.442 . . . . 0.0 111.673 -179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.24 160.27 15.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.252 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.635 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -137.78 94.72 2.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.962 0.411 . . . . 0.0 110.746 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 p -70.45 142.59 51.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.387 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 114' ' ' VAL . . . -68.77 -19.77 64.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.597 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' A' ' 27' ' ' ASN . . . -69.87 -30.82 68.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -104.86 29.92 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . . . -123.68 -165.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.7 m -114.02 104.09 11.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.928 HD12 HG12 ' A' ' 38' ' ' VAL . 1.5 mm -85.43 95.24 4.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 70.4 m -79.95 120.59 24.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.589 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -52.04 155.29 3.32 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.856 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 36' ' ' SER . 56.0 Cg_endo -67.99 4.86 2.49 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.985 -1.256 . . . . 0.0 113.316 0.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.57 142.01 53.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.921 0.391 . . . . 0.0 110.52 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -137.64 145.05 42.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -91.68 95.5 9.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 25' ' ' VAL . 11.5 m -94.61 98.76 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.053 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 60.49 59.96 9.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.577 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.751 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.6 OUTLIER 59.72 20.72 9.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.717 0.294 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 26' ' ' GLY . 1.6 t -131.91 122.96 50.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD1' ' A' ' 113' ' ' ASN . . . -67.22 147.83 49.49 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.203 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 25' ' ' VAL . 5.2 mt-10 -144.48 105.0 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 111.259 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 112' ' ' MET . 0.3 OUTLIER -88.65 159.67 17.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.125 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -154.81 87.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.821 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.2 175.1 45.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.364 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.01 151.05 43.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.08 -27.99 15.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.813 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.57 151.59 37.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.508 0.194 . . . . 0.0 110.483 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 103' ' ' ARG . . . -170.15 107.13 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -89.25 89.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 40' ' ' TRP . 17.6 mm -95.39 157.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 112.523 -178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.839 ' NE1' ' HB2' ' A' ' 16' ' ' ALA . 4.6 m-90 -130.86 146.5 52.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.365 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.18 111.9 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG11 ' CE2' ' A' ' 11' ' ' TYR . 17.2 m -149.82 -176.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -145.65 135.7 23.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.399 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.612 HG13 ' HE2' ' A' ' 50' ' ' TYR . 40.3 t -69.24 130.1 91.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.569 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HG3' ' CH2' ' A' ' 9' ' ' TRP . 71.9 Cg_endo -76.92 -45.01 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.343 2.029 . . . . 0.0 113.033 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.507 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -122.28 163.67 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 111.881 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 95' ' ' ALA . 41.1 p -94.79 72.28 3.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.26 -132.62 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.802 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.819 ' OE2' HD21 ' A' ' 122' ' ' LEU . 37.0 tt0 -132.16 149.42 52.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.954 0.407 . . . . 0.0 111.227 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.832 ' CD2' HD23 ' A' ' 93' ' ' LEU . 20.5 m-85 -137.57 160.83 38.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.232 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.573 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.25 128.27 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.746 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.679 HD12 ' CE ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -99.13 149.05 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.241 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' A' ' 86' ' ' THR . 0.1 OUTLIER -148.42 119.44 7.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.551 ' CD2' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.58 123.86 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.162 0.506 . . . . 0.0 111.04 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 133.78 51.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.266 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.547 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -157.9 154.54 28.07 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.342 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -161.82 81.19 0.57 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.656 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -116.44 90.68 31.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.487 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 31.3 Cg_exo -61.59 61.58 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.215 1.944 . . . . 0.0 113.504 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -166.81 -88.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.5 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -45.19 174.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 45.5 m -173.94 105.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.778 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -171.16 161.45 6.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.05 0.452 . . . . 0.0 111.871 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 65' ' ' ASN . 12.0 t -56.53 163.43 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.699 ' ND2' HG22 ' A' ' 104' ' ' VAL . 24.3 t-20 -160.86 161.5 31.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.039 0.447 . . . . 0.0 111.433 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.573 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -103.12 137.19 41.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' CG1' ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.49 107.61 18.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -91.06 96.85 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.886 0.374 . . . . 0.0 110.953 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.551 ' HE1' ' CD2' ' A' ' 54' ' ' LEU . 4.4 mmt -132.95 114.4 13.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.432 ' N ' ' CE1' ' A' ' 100' ' ' PHE . 20.4 t0 65.55 41.69 4.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.1 26.07 71.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.625 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -128.64 122.88 31.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -100.43 93.89 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 1.4 pp -83.21 127.45 33.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.045 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.1 t -79.91 122.14 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -155.71 151.27 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.204 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.44 125.86 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.139 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' CD2' ' CZ2' ' A' ' 56' ' ' TRP . 8.3 m-85 -133.88 94.99 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.831 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 62' ' ' SER . . . -86.79 132.14 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.607 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.543 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.5 OUTLIER -51.45 88.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.68 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.64 161.47 29.66 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.262 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.487 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -103.21 -33.96 9.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.947 0.403 . . . . 0.0 110.995 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 85' ' ' VAL . 49.5 t -79.89 136.09 54.91 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.328 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.27 82.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.347 2.031 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 83' ' ' VAL . 23.1 t -84.05 139.5 17.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.32 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.733 HG22 ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -122.54 114.3 20.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.973 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -93.73 105.66 17.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 38.3 t -79.93 129.52 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.459 ' OE1' HD21 ' A' ' 74' ' ' LEU . 4.7 mt-30 -144.22 127.76 17.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.2 p -104.8 137.28 42.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.933 0.397 . . . . 0.0 111.06 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.74 ' HG2' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.83 156.53 25.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.312 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.789 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -92.34 134.58 34.78 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.898 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.48 144.36 51.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.902 178.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 p -102.58 143.69 31.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' H ' HG22 ' A' ' 47' ' ' THR . . . -49.83 122.05 6.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.371 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.08 -155.86 26.36 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -94.8 129.29 41.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -144.2 135.92 26.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -88.12 128.79 35.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.685 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CE1' ' N ' ' A' ' 70' ' ' ASP . 27.2 m-85 -128.42 147.39 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' HA2' ' CZ3' ' A' ' 40' ' ' TRP . . . 159.33 -155.4 26.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.194 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.715 ' CG1' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -144.07 122.89 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.713 -0.244 . . . . 0.0 110.447 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -127.6 173.22 10.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.154 0.502 . . . . 0.0 111.894 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.699 HG22 ' ND2' ' A' ' 65' ' ' ASN . 47.0 t -126.89 128.28 70.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.659 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -144.43 -170.96 14.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.792 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -59.51 -37.43 78.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -62.06 -28.99 69.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.8 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -158.1 88.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.441 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -90.05 145.65 24.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.895 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.25 170.52 18.25 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.814 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.79 149.24 22.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.9 tpt -164.41 130.04 2.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.662 0.268 . . . . 0.0 111.174 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.576 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 26.8 t30 -80.78 172.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 38' ' ' VAL . 11.0 t -153.85 119.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 116' ' ' SER . 0.1 OUTLIER -96.82 -58.94 1.91 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.99 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -179.41 144.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.738 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 8.1 mp -88.31 159.84 17.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 9.6 tppt? -136.29 140.57 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.419 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -150.0 107.94 3.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -124.15 178.29 5.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.193 0.52 . . . . 0.0 111.752 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.95 59.48 2.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.091 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.819 HD21 ' OE2' ' A' ' 49' ' ' GLU . 6.0 mp 43.09 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.519 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.451 ' CZ3' ' HG3' ' A' ' 45' ' ' PRO . 20.0 m-90 -158.46 106.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.476 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.429 HG23 ' CB ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -98.31 148.71 23.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.276 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CB ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -124.83 100.75 6.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.653 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 p -66.85 148.9 51.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.52 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . -63.15 -24.08 67.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.498 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.82 -24.71 63.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 94.1 p -107.31 29.53 7.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.765 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.798 ' HB2' ' NE1' ' A' ' 40' ' ' TRP . . . -124.6 -165.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.75 104.21 12.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.796 ' CD1' HD23 ' A' ' 24' ' ' LEU . 15.6 mm -79.79 98.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.624 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 60.3 m -83.8 115.96 22.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.194 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.556 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -51.65 154.0 3.69 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.743 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 36' ' ' SER . 53.0 Cg_endo -66.82 1.94 2.58 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.11 -1.204 . . . . 0.0 113.472 0.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 19' ' ' THR . . . -59.4 141.66 54.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.592 ' HA ' HG21 ' A' ' 18' ' ' ILE . 9.5 tt0 -141.65 144.61 34.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.539 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.796 HD23 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.93 91.04 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.782 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 25' ' ' VAL . 5.2 m -90.38 109.34 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.742 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 61.63 55.51 28.31 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.684 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 3.7 m120 58.49 20.88 7.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.86 0.362 . . . . 0.0 111.195 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 26' ' ' GLY . 3.6 t -134.61 144.55 34.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.232 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' VAL . . . -78.5 143.17 26.7 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.762 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.8 OUTLIER -144.15 110.76 5.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 111.639 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.785 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -88.52 170.36 10.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.578 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 2.0 tt0 -159.98 113.6 2.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.754 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.24 169.09 1.64 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.664 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.55 42.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.26 -13.27 44.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.245 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -99.26 156.77 16.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.981 0.39 . . . . 0.0 110.736 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -170.21 144.24 2.56 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.34 89.47 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.027 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.701 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 28.4 mm -90.12 157.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.176 0.512 . . . . 0.0 112.281 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.802 ' CZ3' HD23 ' A' ' 117' ' ' LEU . 1.4 m-90 -133.07 149.06 52.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.663 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -106.73 111.67 24.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.119 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.442 HG11 ' CE1' ' A' ' 11' ' ' TYR . 27.3 m -151.0 -179.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.508 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -153.58 111.95 3.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.718 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 95' ' ' ALA . 2.4 m -54.77 143.18 51.59 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.902 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 9' ' ' TRP . 58.7 Cg_endo -73.53 -52.65 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.49 2.126 . . . . 0.0 113.014 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 47' ' ' THR . 20.7 t -115.35 159.99 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-O 121.218 0.532 . . . . 0.0 111.835 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 47' ' ' THR . 1.1 m -86.88 88.26 7.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.733 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.49 -137.11 2.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.603 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.758 ' OE1' HD11 ' A' ' 122' ' ' LEU . 3.9 tt0 -129.05 137.43 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.675 ' CD1' HD23 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -124.74 159.45 30.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.768 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 110.32 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.288 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 52' ' ' ILE . 1.1 mm -84.11 119.45 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 111.464 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -109.8 124.37 51.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.513 ' HG ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -99.44 124.91 45.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.17 0.51 . . . . 0.0 110.944 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 4.0 m -117.04 132.73 56.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.566 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.485 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 0.0 OUTLIER -146.03 161.81 39.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.805 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.4 p -160.4 72.26 0.47 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.099 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.595 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 0.6 OUTLIER -111.1 90.83 12.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.642 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.468 ' CA ' ' HB ' ' A' ' 82' ' ' THR . 51.3 Cg_exo -53.73 81.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.935 1.757 . . . . 0.0 112.594 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 58' ' ' SER . 7.1 t80 -176.12 -115.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.433 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.504 ' N ' ' HB2' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 179.11 146.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.354 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.518 ' OG ' ' HA ' ' A' ' 79' ' ' ALA . 11.6 p -140.73 -135.14 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 62' ' ' SER . 6.6 mtmt -165.56 174.2 10.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.036 0.446 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 21.6 t -38.12 140.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.605 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.567 ' OD1' HG22 ' A' ' 104' ' ' VAL . 1.6 t-20 -148.6 169.25 20.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.967 HG22 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.46 137.6 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.861 HD13 HG13 ' A' ' 102' ' ' VAL . 13.1 tp -118.85 109.98 16.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.016 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 22.7 t -85.65 99.08 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.567 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.795 ' HE3' HD11 ' A' ' 67' ' ' LEU . 37.1 mtt -131.26 106.75 8.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.126 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.613 ' CG ' HD12 ' A' ' 93' ' ' LEU . 43.5 t0 90.18 24.03 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.89 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.08 17.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.823 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 149.35 23.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -104.19 108.86 20.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.508 HD21 HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -87.86 144.4 26.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.131 -179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -82.25 131.5 35.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.408 ' O ' HG13 ' A' ' 64' ' ' VAL . 8.8 t80 -160.02 151.25 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -79.5 122.73 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.456 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.15 139.36 51.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.476 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' OG ' ' A' ' 62' ' ' SER . . . -124.45 168.4 13.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.355 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 14.3 mt-10 -95.99 88.18 4.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -94.98 142.89 26.95 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.895 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.468 ' HB ' ' CA ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -81.21 -31.63 33.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.735 0.302 . . . . 0.0 111.42 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 85' ' ' VAL . 74.3 t -79.4 132.89 61.01 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.562 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.0 81.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.47 2.113 . . . . 0.0 111.857 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 83' ' ' VAL . 22.3 t -79.73 132.82 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.006 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 1.7 p -112.62 146.51 38.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 41.7 t80 -141.9 109.77 5.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.601 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.4 HG22 ' ND2' ' A' ' 53' ' ' ASN . 40.6 t -79.62 145.86 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.749 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.34 112.84 5.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.31 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 p -83.94 117.63 23.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.984 0.421 . . . . 0.0 110.939 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HZ3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -144.41 156.2 44.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 -179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.8 ' C ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -94.83 125.87 39.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.085 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -122.54 141.92 51.16 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.951 178.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -103.86 147.54 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.07 0.462 . . . . 0.0 111.228 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 44' ' ' VAL . . . -52.67 134.56 35.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.236 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.86 -156.55 25.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.559 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 116.97 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -136.18 136.55 40.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.9 m -95.91 146.88 24.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.543 ' CE2' HD11 ' A' ' 119' ' ' LEU . 7.6 m-85 -139.39 159.07 43.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 111.213 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CZ3' ' A' ' 40' ' ' TRP . . . 154.92 -154.41 25.5 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.079 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.861 HG13 HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -136.42 118.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 110.488 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -100.73 160.75 14.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.43 0.633 . . . . 0.0 112.361 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.785 ' CG2' HD13 ' A' ' 31' ' ' LEU . 41.5 t -130.21 108.17 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.53 -176.95 19.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.8 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 m -67.55 -41.47 84.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.11 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.795 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -143.83 96.82 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -118.39 137.93 52.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 95.39 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.589 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -37.94 132.28 0.98 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.311 0.244 . . . . 0.0 111.361 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 8.2 ptm -157.11 157.26 34.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.515 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -80.64 155.98 26.59 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.514 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 38' ' ' VAL . 48.2 t -139.55 96.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.526 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 2.2 t60 -69.22 -56.3 8.0 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 p -177.96 159.92 1.4 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.716 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.802 HD23 ' CZ3' ' A' ' 40' ' ' TRP . 1.6 mm? -106.9 97.79 7.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.228 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CB ' HG23 ' A' ' 10' ' ' THR . 7.7 tttm -85.21 130.23 34.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.268 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.595 HD23 ' CB ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -130.03 107.74 9.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.051 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 1.5 tt0 -105.97 167.2 9.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 111.615 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.632 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -81.09 54.44 2.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.644 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.758 HD11 ' OE1' ' A' ' 49' ' ' GLU . 1.7 mt 57.65 178.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.898 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 6.7 p90 -140.13 137.18 34.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.57 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.791 HG23 ' HG2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -115.09 158.7 21.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.461 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -135.85 101.34 4.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 116' ' ' SER . 0.0 OUTLIER -59.12 158.06 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.783 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.61 -16.83 64.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.974 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.87 -15.2 63.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.303 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -111.34 -11.84 14.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.115 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.956 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . . . -79.86 -166.12 0.95 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 m -111.55 103.94 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.925 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.753 HD13 HG12 ' A' ' 38' ' ' VAL . 22.0 mm -82.83 95.11 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.0 m -90.19 114.38 26.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.447 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HA ' ' N ' ' A' ' 22' ' ' ALA . . . -45.33 147.76 1.28 Allowed Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 20' ' ' ALA . 45.9 Cg_endo -65.9 6.44 1.25 Allowed 'Cis proline' 0 C--N 1.351 0.664 0 C-N-CA 124.286 -1.131 . . . . 0.0 114.018 0.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 30' ' ' GLU . . . -59.17 138.61 57.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.242 0.544 . . . . 0.0 110.706 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 59.7 tp60 -137.58 147.78 45.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -93.37 90.57 6.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.1 0.476 . . . . 0.0 111.402 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.9 p -94.18 99.84 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.251 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 59.17 64.95 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.937 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.669 ' HA ' HD11 ' A' ' 24' ' ' LEU . 8.5 p30 51.88 24.67 2.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' GLY . 20.2 t -135.73 123.97 37.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' ASN . . . -51.17 177.1 0.06 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.825 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.4 mt-10 -158.13 78.43 0.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.483 0.182 . . . . 0.0 110.766 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -78.85 158.77 28.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' O ' HG21 ' A' ' 104' ' ' VAL . 24.8 mt-30 -139.08 -121.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.103 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.78 -170.09 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.78 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.41 150.18 48.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.2 -28.07 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.834 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.663 ' HB2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.63 152.51 43.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.579 0.228 . . . . 0.0 110.46 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.95 134.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -113.1 89.61 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.0 151.9 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.267 0.556 . . . . 0.0 112.211 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.956 ' CE2' ' HB2' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -124.3 148.55 47.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.623 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 42' ' ' VAL . 9.4 m120 -110.07 115.77 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.73 HG11 ' CE2' ' A' ' 11' ' ' TYR . 2.5 m -157.81 179.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.05 147.96 52.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.028 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.665 HG13 ' CE2' ' A' ' 50' ' ' TYR . 3.7 t -93.1 124.31 58.45 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.81 -48.45 21.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.59 2.193 . . . . 0.0 112.823 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 -172.95 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.855 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 p -106.0 93.34 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.03 -173.92 29.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' O ' HD12 ' A' ' 122' ' ' LEU . 24.4 tt0 -97.07 110.75 23.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.135 0.493 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.665 ' CE2' HG13 ' A' ' 44' ' ' VAL . 6.2 m-30 -93.2 155.64 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.24 103.79 16.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.379 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' CD ' ' A' ' 91' ' ' LYS . 2.9 mp -94.13 149.1 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.515 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 20.6 p30 -145.54 131.25 18.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.967 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.753 ' HG ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.81 135.46 41.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 137.3 54.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.518 ' CZ3' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -141.58 161.84 36.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.0 t -160.21 77.87 0.65 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.343 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 81' ' ' ALA . 12.9 t -120.49 99.29 47.92 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.29 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' CB ' ' HB ' ' A' ' 82' ' ' THR . 27.2 Cg_exo -65.93 47.88 0.22 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.682 2.254 . . . . 0.0 114.62 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CD2' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -143.07 -85.01 0.15 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.974 -0.454 . . . . 0.0 111.709 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 80' ' ' GLU . 10.1 t 176.4 160.7 0.34 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 112' ' ' MET . 1.1 t -137.48 -141.07 0.15 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.58 175.0 0.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.774 0.321 . . . . 0.0 110.401 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 77' ' ' ALA . 12.1 t -44.22 146.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.662 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.701 HD21 HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -160.87 169.29 22.95 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.959 0.409 . . . . 0.0 111.836 -179.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.43 137.06 47.01 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.817 HD13 HG13 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -101.5 104.11 15.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.674 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 103' ' ' ARG . 16.8 t -90.83 96.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.868 0.366 . . . . 0.0 111.131 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.852 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.0 mmt -121.92 115.69 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.667 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.592 ' CG ' HD12 ' A' ' 93' ' ' LEU . 3.1 t70 69.65 25.67 5.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.79 -26.18 21.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.714 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 138.23 32.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.688 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LEU . . . -113.64 105.38 13.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.52 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -89.59 146.93 24.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.621 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.5 m -79.99 105.66 11.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.977 0.418 . . . . 0.0 110.653 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.24 108.96 11.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' A' ' 64' ' ' VAL . . . -98.16 139.0 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.615 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -173.24 179.45 2.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 112.089 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' O ' ' CZ3' ' A' ' 56' ' ' TRP . . . -104.16 -162.62 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.984 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 0.1 OUTLIER -124.4 109.37 13.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.0 110.493 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -93.73 152.45 18.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -79.85 -32.13 40.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.006 0.432 . . . . 0.0 110.736 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 85' ' ' VAL . 83.7 t -79.67 139.48 54.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.015 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 83' ' ' VAL . 31.9 Cg_exo -59.61 78.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.25 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 83' ' ' VAL . 40.6 t -79.91 132.14 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -109.5 155.44 21.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 15.0 t80 -137.04 146.58 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.889 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.408 ' O ' ' CZ ' ' A' ' 87' ' ' TYR . 21.3 t -96.05 138.05 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -156.13 114.86 3.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.59 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 37.1 p -102.67 138.82 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.413 . . . . 0.0 111.2 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -160.28 156.26 26.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.512 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.842 ' C ' HD13 ' A' ' 93' ' ' LEU . 11.4 p -90.42 128.61 36.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.816 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -118.04 153.96 32.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.417 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 p -104.31 163.12 12.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 111.026 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.13 142.8 45.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.52 -144.22 16.39 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.56 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.56 136.0 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.826 0.346 . . . . 0.0 110.966 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -141.76 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 t -117.09 121.0 40.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.044 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 117' ' ' LEU . 36.0 m-85 -119.55 153.52 35.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.532 ' HA2' HD13 ' A' ' 117' ' ' LEU . . . 160.3 -161.93 32.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.056 -1.069 . . . . 0.0 113.534 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.817 HG13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.14 120.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG2' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -124.93 -179.92 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 111.864 -179.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.766 HG13 ' HA ' ' A' ' 109' ' ' TRP . 57.5 t -108.8 132.08 57.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.141 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.76 179.14 36.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.8 m -79.08 -50.19 11.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 111.037 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -75.79 -29.18 58.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.067 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.688 ' HB3' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 -122.36 101.1 7.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.766 ' HA ' HG13 ' A' ' 104' ' ' VAL . 30.8 p90 -123.47 143.5 50.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.022 0.439 . . . . 0.0 111.421 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -170.17 128.01 1.57 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.027 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -70.53 106.65 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.64 0.22 . . . . 0.0 110.609 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.635 ' SD ' HG23 ' A' ' 114' ' ' VAL . 4.6 ppp? -131.11 148.33 52.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.901 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.629 ' HB3' HG12 ' A' ' 28' ' ' VAL . 3.0 m120 -93.75 153.38 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 38' ' ' VAL . 10.9 t -121.98 113.06 37.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 0.0 111.921 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.541 ' N ' HG13 ' A' ' 28' ' ' VAL . 3.8 t-160 -73.51 -58.17 3.49 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.451 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 1.2 p -178.29 147.22 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.647 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.852 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -97.64 129.21 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.692 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.791 ' HG2' HG23 ' A' ' 10' ' ' THR . 0.4 OUTLIER -115.11 143.11 45.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 111.645 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -141.83 113.13 7.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -107.81 -177.09 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.693 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -93.9 26.3 3.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER 54.47 74.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.563 -179.991 . . . . . . . . 0 0 . 1 stop_ save_